
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            Targeting Src tyrosine kinase to enhance radioiodide uptake in breast cancer - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="152545B38AF31AD30545B3000C3CEBC4.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="sfesd">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372067/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="Endocrine-Related Cancer">
<meta name="citation_title" content="Targeting Src tyrosine kinase to enhance radioiodide uptake in breast cancer">
<meta name="citation_author" content="Vikki L Poole">
<meta name="citation_author_institution" content="Department of Metabolism &amp; Systems Science (MSS) and Centre for Endocrinology, Diabetes and Metabolism (CEDAM), College of Medicine and Health, University of Birmingham, Birmingham, UK">
<meta name="citation_author" content="Mohammed M Alshahrani">
<meta name="citation_author_institution" content="Department of Metabolism &amp; Systems Science (MSS) and Centre for Endocrinology, Diabetes and Metabolism (CEDAM), College of Medicine and Health, University of Birmingham, Birmingham, UK">
<meta name="citation_author" content="Selvambigai Manivannan">
<meta name="citation_author_institution" content="Department of Metabolism &amp; Systems Science (MSS) and Centre for Endocrinology, Diabetes and Metabolism (CEDAM), College of Medicine and Health, University of Birmingham, Birmingham, UK">
<meta name="citation_author" content="Iñigo Landa">
<meta name="citation_author_institution" content="Institut Gustave Roussy, Inserm U981, Villejuif, France">
<meta name="citation_author_institution" content="IHU-National PRecISion Medicine Center in Oncology, Villejuif, France">
<meta name="citation_author" content="Aditi Hariharan">
<meta name="citation_author_institution" content="Department of Metabolism &amp; Systems Science (MSS) and Centre for Endocrinology, Diabetes and Metabolism (CEDAM), College of Medicine and Health, University of Birmingham, Birmingham, UK">
<meta name="citation_author" content="Rebecca J Thompson">
<meta name="citation_author_institution" content="Department of Metabolism &amp; Systems Science (MSS) and Centre for Endocrinology, Diabetes and Metabolism (CEDAM), College of Medicine and Health, University of Birmingham, Birmingham, UK">
<meta name="citation_author" content="Merve Kocbiyik">
<meta name="citation_author_institution" content="Department of Metabolism &amp; Systems Science (MSS) and Centre for Endocrinology, Diabetes and Metabolism (CEDAM), College of Medicine and Health, University of Birmingham, Birmingham, UK">
<meta name="citation_author" content="Caitlin E M Thornton">
<meta name="citation_author_institution" content="Department of Metabolism &amp; Systems Science (MSS) and Centre for Endocrinology, Diabetes and Metabolism (CEDAM), College of Medicine and Health, University of Birmingham, Birmingham, UK">
<meta name="citation_author" content="Katie Brookes">
<meta name="citation_author_institution" content="Department of Metabolism &amp; Systems Science (MSS) and Centre for Endocrinology, Diabetes and Metabolism (CEDAM), College of Medicine and Health, University of Birmingham, Birmingham, UK">
<meta name="citation_author" content="Alice Fletcher">
<meta name="citation_author_institution" content="Department of Metabolism &amp; Systems Science (MSS) and Centre for Endocrinology, Diabetes and Metabolism (CEDAM), College of Medicine and Health, University of Birmingham, Birmingham, UK">
<meta name="citation_author" content="Kristien Boelaert">
<meta name="citation_author_institution" content="Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK">
<meta name="citation_author" content="Martin L Read">
<meta name="citation_author_institution" content="Department of Metabolism &amp; Systems Science (MSS) and Centre for Endocrinology, Diabetes and Metabolism (CEDAM), College of Medicine and Health, University of Birmingham, Birmingham, UK">
<meta name="citation_author" content="Christopher J McCabe">
<meta name="citation_author_institution" content="Department of Metabolism &amp; Systems Science (MSS) and Centre for Endocrinology, Diabetes and Metabolism (CEDAM), College of Medicine and Health, University of Birmingham, Birmingham, UK">
<meta name="citation_author" content="Vicki E Smith">
<meta name="citation_author_institution" content="Department of Metabolism &amp; Systems Science (MSS) and Centre for Endocrinology, Diabetes and Metabolism (CEDAM), College of Medicine and Health, University of Birmingham, Birmingham, UK">
<meta name="citation_publication_date" content="2025 Aug 20">
<meta name="citation_volume" content="32">
<meta name="citation_issue" content="8">
<meta name="citation_firstpage" content="e240312">
<meta name="citation_doi" content="10.1530/ERC-24-0312">
<meta name="citation_pmid" content="40748136">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372067/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372067/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372067/pdf/ERC-24-0312.pdf">
<meta name="description" content="Sodium iodide symporter (NIS) expression in breast cancer renders radioiodide (RAI) a promising treatment modality. However, insufficient functional NIS within the plasma membrane limits RAI uptake (RAIU). We aimed to elucidate NIS regulatory ...">
<meta name="og:title" content="Targeting Src tyrosine kinase to enhance radioiodide uptake in breast cancer">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Sodium iodide symporter (NIS) expression in breast cancer renders radioiodide (RAI) a promising treatment modality. However, insufficient functional NIS within the plasma membrane limits RAI uptake (RAIU). We aimed to elucidate NIS regulatory ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372067/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://www.ncbi.nlm.nih.gov/pmc/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
                
                    <button form="pmc-search-form" formaction="https://pmc.ncbi.nlm.nih.gov/search/" type="submit" class="usa-button usa-button--unstyled hover:text-no-underline text-no-underline width-auto margin-top-1 tablet:margin-top-0">
     <span class="bg-green-label padding-05 text-white">New</span><span class="text-underline text-primary">Try this search in PMC Beta Search</span>
</button>
                
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="12372067">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.1530/ERC-24-0312"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/ERC-24-0312.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12372067%2F%3Freport%3Dclassic%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/12372067/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/12372067/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372067/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-sfesd.png" alt="Society for Endocrinology Open Access logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to Society for Endocrinology Open Access" title="Link to Society for Endocrinology Open Access" shape="default" href="https://doi.org/10.1530/ERC-24-0312" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Endocr Relat Cancer</button></div>. 2025 Aug 20;32(8):e240312. doi: <a href="https://doi.org/10.1530/ERC-24-0312" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.1530/ERC-24-0312</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/pmc/?term=%22Endocr%20Relat%20Cancer%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Endocr%20Relat%20Cancer%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Endocr%20Relat%20Cancer%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Endocr%20Relat%20Cancer%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>Targeting Src tyrosine kinase to enhance radioiodide uptake in breast cancer</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Poole%20VL%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Vikki L Poole</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Vikki L Poole</span></h3>
<div class="p">
<sup><sup>1</sup></sup>Department of Metabolism &amp; Systems Science (MSS) and Centre for Endocrinology, Diabetes and Metabolism (CEDAM), College of Medicine and Health, University of Birmingham, Birmingham, UK</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Poole%20VL%22%5BAuthor%5D" class="usa-link"><span class="name western">Vikki L Poole</span></a>
</div>
</div>
<sup>1,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Alshahrani%20MM%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Mohammed M Alshahrani</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Mohammed M Alshahrani</span></h3>
<div class="p">
<sup><sup>1</sup></sup>Department of Metabolism &amp; Systems Science (MSS) and Centre for Endocrinology, Diabetes and Metabolism (CEDAM), College of Medicine and Health, University of Birmingham, Birmingham, UK</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Alshahrani%20MM%22%5BAuthor%5D" class="usa-link"><span class="name western">Mohammed M Alshahrani</span></a>
</div>
</div>
<sup>1,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Manivannan%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Selvambigai Manivannan</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Selvambigai Manivannan</span></h3>
<div class="p">
<sup><sup>1</sup></sup>Department of Metabolism &amp; Systems Science (MSS) and Centre for Endocrinology, Diabetes and Metabolism (CEDAM), College of Medicine and Health, University of Birmingham, Birmingham, UK</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Manivannan%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Selvambigai Manivannan</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Landa%20I%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Iñigo Landa</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Iñigo Landa</span></h3>
<div class="p">
<sup><sup>2</sup></sup>Institut Gustave Roussy, Inserm U981, Villejuif, France</div>
<div class="p">
<sup><sup>3</sup></sup>IHU-National PRecISion Medicine Center in Oncology, Villejuif, France</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Landa%20I%22%5BAuthor%5D" class="usa-link"><span class="name western">Iñigo Landa</span></a>
</div>
</div>
<sup>2,</sup><sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hariharan%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Aditi Hariharan</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Aditi Hariharan</span></h3>
<div class="p">
<sup><sup>1</sup></sup>Department of Metabolism &amp; Systems Science (MSS) and Centre for Endocrinology, Diabetes and Metabolism (CEDAM), College of Medicine and Health, University of Birmingham, Birmingham, UK</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Hariharan%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Aditi Hariharan</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Thompson%20RJ%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Rebecca J Thompson</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Rebecca J Thompson</span></h3>
<div class="p">
<sup><sup>1</sup></sup>Department of Metabolism &amp; Systems Science (MSS) and Centre for Endocrinology, Diabetes and Metabolism (CEDAM), College of Medicine and Health, University of Birmingham, Birmingham, UK</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Thompson%20RJ%22%5BAuthor%5D" class="usa-link"><span class="name western">Rebecca J Thompson</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kocbiyik%20M%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Merve Kocbiyik</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Merve Kocbiyik</span></h3>
<div class="p">
<sup><sup>1</sup></sup>Department of Metabolism &amp; Systems Science (MSS) and Centre for Endocrinology, Diabetes and Metabolism (CEDAM), College of Medicine and Health, University of Birmingham, Birmingham, UK</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Kocbiyik%20M%22%5BAuthor%5D" class="usa-link"><span class="name western">Merve Kocbiyik</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Thornton%20CEM%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Caitlin E M Thornton</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Caitlin E M Thornton</span></h3>
<div class="p">
<sup><sup>1</sup></sup>Department of Metabolism &amp; Systems Science (MSS) and Centre for Endocrinology, Diabetes and Metabolism (CEDAM), College of Medicine and Health, University of Birmingham, Birmingham, UK</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Thornton%20CEM%22%5BAuthor%5D" class="usa-link"><span class="name western">Caitlin E M Thornton</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Brookes%20K%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Katie Brookes</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Katie Brookes</span></h3>
<div class="p">
<sup><sup>1</sup></sup>Department of Metabolism &amp; Systems Science (MSS) and Centre for Endocrinology, Diabetes and Metabolism (CEDAM), College of Medicine and Health, University of Birmingham, Birmingham, UK</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Brookes%20K%22%5BAuthor%5D" class="usa-link"><span class="name western">Katie Brookes</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fletcher%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id10"><span class="name western">Alice Fletcher</span></a><div hidden="hidden" id="id10">
<h3><span class="name western">Alice Fletcher</span></h3>
<div class="p">
<sup><sup>1</sup></sup>Department of Metabolism &amp; Systems Science (MSS) and Centre for Endocrinology, Diabetes and Metabolism (CEDAM), College of Medicine and Health, University of Birmingham, Birmingham, UK</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Fletcher%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Alice Fletcher</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Boelaert%20K%22%5BAuthor%5D" class="usa-link" aria-describedby="id11"><span class="name western">Kristien Boelaert</span></a><div hidden="hidden" id="id11">
<h3><span class="name western">Kristien Boelaert</span></h3>
<div class="p">
<sup><sup>4</sup></sup>Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Boelaert%20K%22%5BAuthor%5D" class="usa-link"><span class="name western">Kristien Boelaert</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Read%20ML%22%5BAuthor%5D" class="usa-link" aria-describedby="id12"><span class="name western">Martin L Read</span></a><div hidden="hidden" id="id12">
<h3><span class="name western">Martin L Read</span></h3>
<div class="p">
<sup><sup>1</sup></sup>Department of Metabolism &amp; Systems Science (MSS) and Centre for Endocrinology, Diabetes and Metabolism (CEDAM), College of Medicine and Health, University of Birmingham, Birmingham, UK</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Read%20ML%22%5BAuthor%5D" class="usa-link"><span class="name western">Martin L Read</span></a>
</div>
</div>
<sup>1,</sup><sup>*</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22McCabe%20CJ%22%5BAuthor%5D" class="usa-link" aria-describedby="id13"><span class="name western">Christopher J McCabe</span></a><div hidden="hidden" id="id13">
<h3><span class="name western">Christopher J McCabe</span></h3>
<div class="p">
<sup><sup>1</sup></sup>Department of Metabolism &amp; Systems Science (MSS) and Centre for Endocrinology, Diabetes and Metabolism (CEDAM), College of Medicine and Health, University of Birmingham, Birmingham, UK</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22McCabe%20CJ%22%5BAuthor%5D" class="usa-link"><span class="name western">Christopher J McCabe</span></a>
</div>
</div>
<sup>1,</sup><sup>†</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Smith%20VE%22%5BAuthor%5D" class="usa-link" aria-describedby="id14"><span class="name western">Vicki E Smith</span></a><div hidden="hidden" id="id14">
<h3><span class="name western">Vicki E Smith</span></h3>
<div class="p">
<sup><sup>1</sup></sup>Department of Metabolism &amp; Systems Science (MSS) and Centre for Endocrinology, Diabetes and Metabolism (CEDAM), College of Medicine and Health, University of Birmingham, Birmingham, UK</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Smith%20VE%22%5BAuthor%5D" class="usa-link"><span class="name western">Vicki E Smith</span></a>
</div>
</div>
<sup>1,</sup><sup>†,</sup><sup>✉</sup>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="aff1">
<sup><sup>1</sup></sup>Department of Metabolism &amp; Systems Science (MSS) and Centre for Endocrinology, Diabetes and Metabolism (CEDAM), College of Medicine and Health, University of Birmingham, Birmingham, UK</div>
<div id="aff2">
<sup><sup>2</sup></sup>Institut Gustave Roussy, Inserm U981, Villejuif, France</div>
<div id="aff3">
<sup><sup>3</sup></sup>IHU-National PRecISion Medicine Center in Oncology, Villejuif, France</div>
<div id="aff4">
<sup><sup>4</sup></sup>Department of Applied Health Sciences, College of Medicine and Health, University of Birmingham, Birmingham, UK</div>
<div class="author-notes p">
<div class="fn" id="cor1">
<sup>✉</sup><p class="display-inline">Correspondence should be addressed to V E Smith: <span>v.e.smith@bham.ac.uk</span></p>
</div>
<div class="fn" id="fn1">
<sup>*</sup><p class="display-inline">(V L Poole, M M Alshahrani and M L Read contributed equally to this work)</p>
</div>
<div class="fn" id="fn2">
<sup>
<sup>†</sup>
</sup><p class="display-inline">(C J McCabe and V E Smith contributed equally as senior authors)</p>
</div>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2024 Nov 20; Revised 2025 Jul 10; Accepted 2025 Jul 31; Prepublished 2025 Aug 1; Issue date 2025 Aug 1.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© the author(s)</div>
<p><img class="inline" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b460/12372067/bc114850879e/88x31.jpg" loading="lazy" alt="Inline graphic">This work is licensed under a <a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Creative Commons Attribution 4.0 International License.</a></p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC12372067  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/40748136/" class="usa-link">40748136</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>Sodium iodide symporter (NIS) expression in breast cancer renders radioiodide (RAI) a promising treatment modality. However, insufficient functional NIS within the plasma membrane limits RAI uptake (RAIU). We aimed to elucidate NIS regulatory mechanisms that impede RAIU in breast cancer and identify molecular targets for stimulating RAI-avidity in breast tumours. Mechanistic interaction between pituitary tumor-transforming gene-binding factor (PBF/PTTG1IP) and NIS was investigated through NanoBiT, co-immunoprecipitation, immunofluorescent microscopy, subcellular localisation and RAIU assays utilising wild-type and CRISPR-Cas9 PBF knockout breast cancer cells. In breast cancer cells, NIS:PBF interaction resulted in diminished RAIU, reversible through reduced PBF phosphorylation by the Src inhibitor dasatinib. Src overexpression diminished RAIU in a PBF-dependent manner that was mediated by Src myristoylation by N-myristoyltransferase 1 (NMT1). NMT1 inhibition significantly enhanced RAIU via Src and PBF in breast and thyroid cancer cells. Bioinformatic analyses revealed clinical associations between high Src and NMT1 expression and increased tumour recurrence in RAI-treated thyroid cancers indicating RAI-resistance. In breast cancer, high PBF and Src expression was associated with the more aggressive tumours that are most likely to benefit from targeted RAI therapy. We describe a new NIS regulatory pathway in breast cancer cells via Src myristoylation and PBF phosphorylation and show that the same pathway exists in thyroid cells, the canonical setting for the exploitation of NIS function. These findings reveal that PBF interaction with NIS may be modulated by Src, which in turn is susceptible to NMT inhibition, and suggest that targeting NMT1 may represent an innovative approach for augmenting RAI-avidity in breast cancer.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> NIS, radioiodide, PBF/PTTG1IP, Src myristoylation, breast cancer</p></section></section><section id="sec1"><h2 class="pmc_sec_title">Introduction</h2>
<p>The sodium iodide symporter (NIS) mediates iodide uptake for thyroid hormone biosynthesis and has been successfully utilised for decades to deliver radioiodide (RAI) as a targeted therapeutic for differentiated thyroid cancer (DTC) (<a href="#bib1" class="usa-link" aria-describedby="bib1">1</a>). DTC patients with RAI-resistant metastatic tumours due to reduced NIS expression have an extremely poor prognosis, as do those with more aggressive forms that are inherently RAI-resistant (RAIR), such as anaplastic thyroid cancer (ATC). New therapeutic strategies seek to re-establish NIS expression to restore RAI uptake (RAIU) (<a href="#bib1" class="usa-link" aria-describedby="bib1">1</a>). Furthermore, tumour-targeted NIS gene therapy is an exciting prospect for non-thyroidal tumours (<a href="#bib2" class="usa-link" aria-describedby="bib2">2</a>).</p>
<p>Breast cancer represents a particularly compelling application for radioiodide treatment due to increased endogenous NIS expression in most tumours (70–80%) (<a href="#bib3" class="usa-link" aria-describedby="bib3">3</a>, <a href="#bib4" class="usa-link" aria-describedby="bib4">4</a>, <a href="#bib5" class="usa-link" aria-describedby="bib5">5</a>), including triple negative breast cancer (TNBC) (<a href="#bib6" class="usa-link" aria-describedby="bib6">6</a>) and metastases (<a href="#bib7" class="usa-link" aria-describedby="bib7">7</a>, <a href="#bib8" class="usa-link" aria-describedby="bib8">8</a>), which are often resistant to standard treatments. However, few NIS-positive tumours accumulate RAI (<a href="#bib6" class="usa-link" aria-describedby="bib6">6</a>, <a href="#bib7" class="usa-link" aria-describedby="bib7">7</a>, <a href="#bib8" class="usa-link" aria-describedby="bib8">8</a>, <a href="#bib9" class="usa-link" aria-describedby="bib9">9</a>). This disparity between NIS expression and function suggests inadequate NIS plasma membrane (PM) localisation (<a href="#bib10" class="usa-link" aria-describedby="bib10">10</a>). Thus, understanding how NIS is trafficked in breast cancer cells is crucial to facilitate RAIU.</p>
<p>Diminished NIS PM targeting/retention also contributes to RAIR thyroid cancer and limits strategies to reinduce NIS expression (<a href="#bib11" class="usa-link" aria-describedby="bib11">11</a>). Despite the essential role of membranous NIS in mediating thyroid hormone production and thyroid cancer treatment, its regulation remains to be fully elucidated (<a href="#bib11" class="usa-link" aria-describedby="bib11">11</a>). Our recent work identified endocytosis as a critical determinant of NIS function and, ultimately, patient outcome in thyroid cancer (<a href="#bib12" class="usa-link" aria-describedby="bib12">12</a>).</p>
<p>We identified the first NIS-interacting protein that modulates NIS internalisation and reduces RAIU in thyroid cancer (<a href="#bib13" class="usa-link" aria-describedby="bib13">13</a>). Pituitary tumor-transforming gene-binding factor (PBF/PTTG1IP) is upregulated in thyroid cancer and associated with poorer disease outcomes (<a href="#bib14" class="usa-link" aria-describedby="bib14">14</a>, <a href="#bib15" class="usa-link" aria-describedby="bib15">15</a>). PBF post-translationally regulates NIS function through its binding and endocytosis (<a href="#bib13" class="usa-link" aria-describedby="bib13">13</a>). Subsequently, PBF tyrosine residue 174 (Y174) was found to mediate this effect. We showed that the tyrosine kinase Src could induce PBF phosphorylation at Y174 (PBF-pY174) and, importantly, Src inhibition overcame PBF repression of NIS and restored RAIU in thyroid cancer cells (<a href="#bib16" class="usa-link" aria-describedby="bib16">16</a>). More recently, Src has also been identified as a NIS-interacting protein (<a href="#bib17" class="usa-link" aria-describedby="bib17">17</a>, <a href="#bib18" class="usa-link" aria-describedby="bib18">18</a>).</p>
<p>Here, we investigated whether PBF impedes RAIU in breast cancer cells, given its concurrent upregulation in breast tumours (<a href="#bib19" class="usa-link" aria-describedby="bib19">19</a>), and elucidated the underlying mechanisms of repression. We show that phosphorylated PBF represses RAIU while the Src inhibitor dasatinib restores NIS function in breast cancer cells by inhibiting PBF-pY174. Furthermore, we demonstrate that Src myristoylation, a lipid modification that promotes PM association, mediates RAIU repression via PBF in both breast and thyroid cancer cells, and RAIU is significantly induced by N-myristoyltransferase 1 (NMT1) inhibition. This study reveals that myristolyated Src can repress RAIU via PBF and highlights NMT1 as a potential therapeutic target for the induction of RAIU in breast tumours and the restoration of NIS function in thyroid cancer.</p></section><section id="sec2"><h2 class="pmc_sec_title">Materials and methods</h2>
<section id="sec2-1"><h3 class="pmc_sec_title">Cell lines</h3>
<p>Breast cancer (MCF-7 and MDA-MB-231) and thyroid cancer (TPC-1) cell lines were maintained in RPMI-1640 medium (Thermo Fisher Scientific, USA). TPC-1 cells were obtained from the CU Cancer Center Tissue Culture Shared Resource (University of Colorado). All other cell lines were acquired from ECACC (European Collection of Authenticated Cell Cultures). Cells were supplemented with 10% fetal bovine serum (Thermo Fisher Scientific), penicillin (10<sup>5</sup> U/L), and streptomycin (100 mg/L) and maintained at 37°C and 5% CO<sub>2</sub>. A TPC-1 cell line stably expressing NIS has been described previously and was maintained in RPMI supplemented with blasticidin S (15 μg/mL) (<a href="#bib20" class="usa-link" aria-describedby="bib20">20</a>). Cells were used at low passage (&lt;35) and authenticated by short tandem repeat analysis (Northgene, UK).</p></section><section id="sec2-2"><h3 class="pmc_sec_title">Plasmids and transfection</h3>
<p>Plasmids containing the full-length cDNA for haemagglutinin (HA)-tagged PBF, PBF-Y174A mutant, MYC-tagged NIS and Src have been described previously (<a href="#bib13" class="usa-link" aria-describedby="bib13">13</a>, <a href="#bib14" class="usa-link" aria-describedby="bib14">14</a>, <a href="#bib16" class="usa-link" aria-describedby="bib16">16</a>). The PBF-EEN mutant (<a href="https://www.ncbi.nlm.nih.gov/protein/NP_004330.1" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">NP_004330.1</a>: p.Glu170_Asn172delinsAlaAlaAla) was generated using a QuikChange Site-Directed Mutagenesis Kit (Agilent, USA) with the primers 5′-GAAAAAAATATGGCCTGTTTAAAG<span class="text-underline">C</span>AG<span class="text-underline">C</span>A<span class="text-underline">GC</span>CCCGTATGCTAGATTTG-3′ and 5′-CAAATCTAGCATACGGG<span class="text-underline">GC</span>T<span class="text-underline">G</span>CT<span class="text-underline">G</span>CTTTAAACAGGCCATATTTTTTTC-3′. Nucleotide substitutions are underlined. The Src-T341I mutant was similarly generated using the primers 5′-GAGCCCATTTACATCGTCA<span class="text-underline">TC</span>GAGTACATGAGCAAGGGG-3′ and 5′-CCCCTTGCTCATGTACTC<span class="text-underline">GA</span>TGACGATGTAAATGGGCTC-3′. For the NanoBiT assay, NIS and PBF cDNA were each tagged at the 3′ end with sequences encoding either SmBiT or LgBiT (Promega, USA) within pcDNA3.1+ (Invitrogen, USA) (<a href="#bib12" class="usa-link" aria-describedby="bib12">12</a>).</p>
<p>Plasmid and siRNA transfections were performed with TransIT<sup>®</sup>-LT1 reagent (Mirus Bio, USA) and RNAiMAX (Thermo Fisher), respectively, following manufacturer’s protocols. For stable expression, cells transfected with wild-type (WT) and mutated PBF were selected and maintained in 1 mg/mL G418. For stable PBF knockdown, cells were transduced with lentiviral particles containing shRNA targeting PBF mRNA (SMARTvector Human Lentiviral PTTG1IP – VSH6063/SH-011820; Dharmacon, USA) alongside control shRNA (SMARTvector Non-targeting hCMV-TurboGFP Control Particles – S-005000-01; Dharmacon). For Src knockdown, the ON-TARGETplus Human SRC siRNA SMARTPool was used at a final concentration of 100 nM (Dharmacon).</p></section><section id="sec2-3"><h3 class="pmc_sec_title">Antibodies and reagents</h3>
<p>The following antibodies were used: mouse monoclonal anti-HA.11 (16B12) (Biolegend, USA), rabbit monoclonal anti-HA (C29F4) (Cell Signaling Technology, USA), rabbit PBF-pY174 (CovalAb, France) (<a href="#bib16" class="usa-link" aria-describedby="bib16">16</a>), mouse monoclonal anti-Myc-Tag (9B11) (Cell Signaling Technology), rabbit polyclonal anti-NIS (24324-1-AP) (Proteintech, USA), rabbit monoclonal anti-Src (32G6; 2123) (Cell Signaling), rabbit polyclonal anti-Src-pY418 (ab4816) (Abcam, UK), rabbit polyclonal anti-PBF (Eurogentec, Belgium) (<a href="#bib16" class="usa-link" aria-describedby="bib16">16</a>), rabbit polyclonal anti-PBF (T1205) (Sigma Aldrich, USA) and mouse monoclonal anti–β-actin (clone AC-15) (Sigma).</p>
<p>MCF-7 cells were treated with 100 nM all-trans retinoic acid (ATRA; Sigma) and 1 μM dexamethasone (Sigma) to induce endogenous NIS. Src family kinase inhibitors PP1 (Tocris, UK), dasatinib and saracatinib (Selleck Chemicals, USA) and NMT inhibitor (DDD85646; Drug Discovery Unit, University of Dundee) were dissolved in DMSO to a 10 mM stock concentration. To detect tyrosine phosphorylation, cells were treated with pervanadate (100 μM) for 15 min before protein extraction or immunofluorescence (<a href="#bib16" class="usa-link" aria-describedby="bib16">16</a>).</p></section><section id="sec2-4"><h3 class="pmc_sec_title">NanoBiT live cell protein interaction assays</h3>
<p>MCF-7 cells were seeded in 6-well plates and transfected with 1 μg plasmid DNA (NIS-SmBiT + PBF-LgBiT, NIS-LgBiT + PBF-SmBiT and negative control NIS-SmBiT + LgBiT-PRKAR2A (NanoBiT control vector; Promega)). 24 h post-transfection, cells were reseeded into 96-well plates in phenol red-free DMEM (Thermo Fisher). Nano-Glo<sup>®</sup> Live Cell Reagent (Promega) was added to each well in accordance with the manufacturer’s protocol and measurements were taken every 2 min for 30 min (PHERAstar FS microplate reader; BMG Labtech, Germany).</p></section><section id="sec2-5"><h3 class="pmc_sec_title">Co-immunoprecipitation (co-IP) assays, Western blotting and qPCR</h3>
<p>MCF-7 cells in T75 flasks were transiently transfected with either vector only (VO), NIS-MYC + VO or NIS-MYC + PBF-HA. Co-immunoprecipitation assays were performed as described previously (<a href="#bib13" class="usa-link" aria-describedby="bib13">13</a>) with minor modifications. Cells were lysed in 1 mL RIPA buffer with Dounce homogenisation. Each lysate was incubated with 5 μL anti-Myc-Tag antibody and 100 μL Protein-G-Sepharose 4 Fast Flow beads (GE Healthcare Life Sciences, USA) used to capture antibody–protein complexes.</p>
<p>Western blotting was performed as described previously (<a href="#bib21" class="usa-link" aria-describedby="bib21">21</a>). Proteins (30 μg or co-IP eluate) were separated by SDS-PAGE using 15% acrylamide gels (10% for NIS detection). Membranes were probed with anti-Myc-Tag, anti-HA (16B12), anti-PBF-pY174, anti-PBF, anti-Src, anti-Src-pY418 and anti-β-actin antibodies.</p>
<p>Quantitative PCR (qPCR) was performed as described previously using 18s as the internal housekeeping gene for NIS mRNA expression (<a href="#bib22" class="usa-link" aria-describedby="bib22">22</a>) and using the PBF TaqMan Gene Expression Assay (Hs01036322_m1; Thermo Fisher Scientific).</p></section><section id="sec2-6"><h3 class="pmc_sec_title">Immunofluorescence staining</h3>
<p>MCF-7 cells were seeded onto coverslips in 6-well plates and transfected with 2 μg DNA. Twenty-four hours post-transfection, cells were washed with PBS, fixed in 4% paraformaldehyde/PBS for 15 min and permeabilised with 0.1% saponin. Cells were incubated for 1 h with primary antibodies (mouse-anti-HA, rabbit-anti-HA, and anti-Myc-Tag) and then secondary antibodies (Alexa-Fluor-555-conjugated goat anti-rabbit and Alexa-Fluor-488-conjugated goat anti-mouse; Invitrogen). Finally, coverslips were mounted onto slides using Prolong Gold anti-fade reagent with DAPI (Molecular Probes) and images were captured on an LSM880 Airyscan confocal microscope (100× objective).</p></section><section id="sec2-7"><h3 class="pmc_sec_title">Radioiodide uptake (RAIU) assays</h3>
<p>Cells were seeded into 24-well plates and transfected with 0.5 μg DNA and/or treated with various drugs as stated. RAIU assays were performed 48 h post-transfection, as described previously (<a href="#bib16" class="usa-link" aria-describedby="bib16">16</a>). Before the addition of radioiodide (<sup>125</sup>I), negative control wells were pre-treated for 1 h with the NIS inhibitor, sodium perchlorate (100 μM). All cells were then incubated with 10<sup>−6</sup> M NaI containing 0.05 μCi <sup>125</sup>I (specific activity 17.4 mCi/μg; Hartmann Analytic, Germany) for an hour at 37°C and subsequently washed with Hank’s balanced salt solution (HBSS) to remove unincorporated <sup>125</sup>I. Cells were lysed in 2% SDS and radioactivity was measured in counts per minute using a LKB 1260 Multigamma Gamma Counter. Protein concentration was determined using the Pierce<sup>TM</sup> bicinchoninic acid (BCA) colourimetric assay (Thermo Fisher Scientific) and results given as picomoles iodide per microgram protein.</p></section><section id="sec2-8"><h3 class="pmc_sec_title">Generation of CRISPR-Cas9 PBF knockout cells</h3>
<p>Two 20 bp CRISPR single guide RNA (sgRNA) sequences were designed to target PBF exon 1 via endogenous PAM sequences (Supplementary Fig. 1 (see the section on <a href="#supp1" class="usa-link">Supplementary materials</a> given at the end of the article)). Each sgRNA was cloned into the pLentiCRISPR vector BsmBI restriction sites (Addgene #49535 (<a href="#bib23" class="usa-link" aria-describedby="bib23">23</a>)). Parental MCF-7, MDA-MB-231 and TPC-1 cells were transfected with 400 ng pLentiCRISPR-sgRNA#1–2 using TransIT®-LT1 reagent (Mirus Bio), followed by 1 μg/mL puromycin (Sigma) selection for 3 days. Single cells were plated into 96-well plates and the resultant clones were screened by DNA extraction, PCR, T7 Endonuclease I (T7E; New England Biolabs) mismatch assay and Sanger sequencing. For each cell line, two clones were selected with CRISPR-mediated insertion and/or deletion via two different sgRNA sequences, resulting in a frameshift mutation and significant truncation of PBF.</p></section><section id="sec2-9"><h3 class="pmc_sec_title">Gene expression data analyses</h3>
<p>Gene expression and clinical data for 59 normal thyroid, 488 papillary thyroid cancer (PTC; THCA), 112 normal breast and 1,197 breast cancer (BRCA) samples from The Cancer Genome Atlas (TCGA) were downloaded from FireBrowse (<a href="http://firebrowse.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">http://firebrowse.org/</a>) and cBioPortal (<a href="https://www.cbioportal.org/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://www.cbioportal.org/</a>) (<a href="#bib24" class="usa-link" aria-describedby="bib24">24</a>, <a href="#bib25" class="usa-link" aria-describedby="bib25">25</a>). FPKM (fragments per kilobase transcript per million mapped reads) values were transformed as <em>X</em> = log<sub>2</sub> (X + 1) before analysis. Differential gene expression analysis was also performed using the gene expression omnibus (GEO) dataset <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE60542" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE60542</a> (<a href="#bib26" class="usa-link" aria-describedby="bib26">26</a>, <a href="#bib27" class="usa-link" aria-describedby="bib27">27</a>). Expression data were determined by MSK-IMPACT targeted sequencing from 17 poorly-differentiated thyroid cancer (PDTC) and 20 ATC fresh-frozen samples selected from the Memorial Sloan Kettering Cancer Center Pathology Department (1986–2015) according to the classification outlined in (<a href="#bib28" class="usa-link" aria-describedby="bib28">28</a>).</p></section><section id="sec2-10"><h3 class="pmc_sec_title">Patient survival characteristics</h3>
<p>Receiver operating characteristic (ROC) curves were plotted in IBM SPSS Statistics (version 29) with the area under the curve (AUC) representing the accuracy of potential gene biomarkers for distinguishing recurrent from non-recurrent disease. Using the classifier evaluation metrics output data, patients were stratified into high and low expression groups for gene biomarkers based on optimal cut-off values for sensitivity and specificity. Disease-free survival (DFS) characteristics (i.e. Kaplan–Meier (log-rank test) and univariate Cox regression analyses) were also determined using optimal expression cut-off values.</p></section><section id="sec2-11"><h3 class="pmc_sec_title">Statistical analyses</h3>
<p>Data were analysed using the Student’s <em>t</em>-test and Mann–Whitney U test for comparison between two groups of parametric and nonparametric data, respectively. One-way ANOVA with Tukey’s post-hoc test and a Kruskal–Wallis test with Dunn’s post-hoc test were used for comparisons of multiple groups of parametric and nonparametric data, respectively. <em>P</em>-values were adjusted using the Benjamini–Hochberg FDR correction procedure to correct for multiple comparisons. Significance was taken as <em>P</em> &lt; 0.05. All <em>P</em>-values reported from statistical tests were two-sided.</p></section></section><section id="sec3"><h2 class="pmc_sec_title">Results</h2>
<section id="sec3-1"><h3 class="pmc_sec_title">Phosphorylated PBF represses RAIU in breast cancer cells</h3>
<p>Previously, we showed that PBF interacts with NIS in thyroid cancer cells, via PBF-Y174, resulting in diminished RAIU (<a href="#bib13" class="usa-link" aria-describedby="bib13">13</a>, <a href="#bib16" class="usa-link" aria-describedby="bib16">16</a>). Using NanoBiT assays, we now confirm a robust and dynamic interaction between NIS and PBF in live MCF-7 breast cancer cells (<a href="#fig1" class="usa-link">Fig. 1A</a>), supported by co-immunoprecipitation assays (<a href="#fig1" class="usa-link">Fig. 1B</a>).</p>
<figure class="fig xbox font-sm" id="fig1"><h4 class="obj_head">Figure 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372067_ERC-24-0312fig1.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b460/12372067/23820d84feb7/ERC-24-0312fig1.jpg" loading="lazy" height="944" width="786" alt="Figure 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig1/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Phosphorylated PBF represses RAIU in breast cancer cells. (A) <em>Left</em> – schematic of the interaction between NIS and PBF proteins tagged at the C-terminus with the NanoLuc luciferase subunits LgBiT and SmBiT, respectively. In close proximity, LgBiT and SmBiT form a functional enzyme that uses the substrate furimazine to produce a high-intensity, luminescent signal. Created using Alphafold (<a href="#bib59" class="usa-link" aria-describedby="bib59">59</a>, <a href="#bib60" class="usa-link" aria-describedby="bib60">60</a>) and BioRender. <em>Right</em> – NanoBiT analysis of NIS:PBF interaction in MCF-7 cells, with bar graph showing results at 20 min post-addition of Nano-Glo live cell assay substrate. (B) Co-immunoprecipitation assay showing PBF-HA and NIS-MYC interaction in MCF-7 breast cancer cells. (C) Schematic of PBF highlighting the overlapping phosphorylation site and endocytosis motif at the C-terminus, and the PBF-Y174A and E170_N172delinsAAA (PBF-EEN MUT) mutants. (D) Western blot showing the phosphorylation status of PBF-Y174A and PBF-EEN MUT compared with PBF-WT in MCF-7 cells. (E) Immunofluorescent images showing PBF-WT, PBF-Y174A and PBF-EEN MUT localisation in MCF-7 cells. (F) Immunofluorescent images showing subcellular localisation following the co-transfection of NIS-MYC (green) with VO, PBF-WT, PBF-Y174A or PBF-EEN MUT (red) in MCF-7 cells. Co-localisation is seen in yellow. (G) The effect of PBF and phosphomutants (Y174A/EEN-MUT) on RAIU in MCF-7 (i) and MDA-MB-231 (ii) cells transiently co-transfected with NIS-MYC. (H) The effect of PBF and phosphomutants (Y174A/EEN-MUT) on RAIU in MCF-7 cells treated with ATRA and dexamethasone. VO = vector only control. Bars = 10 μm. <em>n</em> = 3 for all experiments. Error bars = SEM. Significance shown compared with VO unless otherwise shown. ns = not significant (<em>P</em> &gt; 0.05), * = <em>P</em> &lt; 0.05, ** = <em>P</em> &lt; 0.01, *** = <em>P</em> &lt; 0.001.</p></figcaption></figure><p>Intriguingly, in addition to a Src-mediated phosphorylation site, PBF-Y174 is the key residue in a tyrosine-based sorting signal (YXXφ; <a href="#fig1" class="usa-link">Fig. 1C</a>) required for PBF endocytosis from the PM (<a href="#bib16" class="usa-link" aria-describedby="bib16">16</a>). To specifically assess the impact of PBF phosphorylation, part of the Src consensus sequence preceding Y174 was mutated (PBF E170_N172delinsAAA; PBF-EEN-MUT). Similar to PBF-Y174A, PBF-EEN-MUT lacked Y174 phosphorylation (<a href="#fig1" class="usa-link">Fig. 1D</a>), but immunofluorescence microscopy confirmed that, whereas PBF-Y174A showed increased PM accumulation, PBF-EEN-MUT retained subcellular distribution comparable with WT PBF (<a href="#fig1" class="usa-link">Fig. 1E</a>). As in thyroid cancer cells, there was extensive co-localisation between NIS and PBF-WT within intracellular vesicles in breast cancer cells, while NIS co-localisation with PBF-Y174A was limited to the PM (<a href="#fig1" class="usa-link">Fig. 1F</a>). In contrast PBF-EEN-MUT appeared to co-localise more weakly with NIS, which remained largely expressed at the PM (<a href="#fig1" class="usa-link">Fig. 1F</a>).</p>
<p>Importantly, and in line with thyroid cancer cell data, PBF overexpression significantly repressed RAIU both in oestrogen-responsive MCF-7 breast cancer cells and MDA-MB-231 TNBC cells expressing exogenous NIS (<a href="#fig1" class="usa-link">Fig. 1G</a>). In contrast, neither PBF-EEN-MUT nor PBF-Y174A altered RAIU compared with VO control (<a href="#fig1" class="usa-link">Fig. 1G</a>). All-trans retinoic acid (ATRA) and dexamethasone (Dex) in combination induces NIS expression and RAIU in MCF-7 cells (<a href="#bib29" class="usa-link" aria-describedby="bib29">29</a>) (Supplementary Fig. 2A) and our findings were examined in this model of endogenous NIS expression. ATRA/Dex treatment of MCF-7 cells stably expressing PBF-WT resulted in significantly lower RAIU compared with VO control cells, whereas cells stably expressing PBF-EEN-MUT or PBF-Y174A were comparable with VO cells (<a href="#fig1" class="usa-link">Fig. 1H</a> and Supplementary Fig. 2B). Conversely, although a slight increase in uptake was seen, PBF depletion by shRNA knockdown in MCF-7 cells did not significantly alter ATRA/Dex-stimulated RAIU (Supplementary Fig. 2C).</p>
<p>Taken together, these data demonstrate that NIS and PBF interact within breast cancer cells. A similar mechanism of NIS repression to that seen in thyroid cancer occurs in breast cancer cells, whereby PBF binds and internalises NIS, significantly impairing RAIU. Furthermore, additional phospho-mutants confirmed that this is mediated by PBF phosphorylation at Y174.</p></section><section id="sec3-2"><h3 class="pmc_sec_title">Dasatinib potently inhibits PBF phosphorylation and restores PBF-repressed RAIU</h3>
<p>The Src family kinase (SFK) inhibitor PP1 decreases PBF phosphorylation and restores PBF-mediated RAIU repression in thyroid cancer cells (<a href="#bib16" class="usa-link" aria-describedby="bib16">16</a>). To determine whether SFK inhibition can similarly enhance RAIU in breast cancer cells, MCF-7 and MDA-MB-231 cells were treated with a range of PP1 doses. A marked reduction in PBF phosphorylation was observed from 0.01 μM PP1 treatment in both cell lines (<a href="#fig2" class="usa-link">Fig. 2A</a>) and subsequent PP1 treatment restored PBF-mediated RAIU repression in cells expressing exogenous NIS-MYC (<a href="#fig2" class="usa-link">Fig. 2B</a>), and ATRA/Dex-induced endogenous NIS (<a href="#fig2" class="usa-link">Fig. 2C</a>).</p>
<figure class="fig xbox font-sm" id="fig2"><h4 class="obj_head">Figure 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372067_ERC-24-0312fig2.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b460/12372067/a3e5ac10a49a/ERC-24-0312fig2.jpg" loading="lazy" height="946" width="698" alt="Figure 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig2/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Src inhibition inhibits PBF phosphorylation and restores RAIU. (A) MCF-7 (i) and MDA-MB-231 (ii) cells were treated with varying doses of PP1 (0–2 μM) for 24 h before PBF-pY174 and total PBF expression levels were determined by Western blot. (B) Effect of 2 μM PP1 treatment on PBF-mediated RAIU repression in MCF-7 (i) and MDA-MB-231 (ii) cells transiently co-transfected with NIS-MYC. (C) Effect of 2 μM PP1 treatment on PBF-mediated RAIU repression in MCF-7 cells treated with ATRA and dexamethasone. (D) PBF-pY174 and total PBF expression levels following dasatinib dose response (0–2 μM) treatment for 24 h in MCF-7 (i) and MDA-MB-231 (ii) cells. (E) Effect of 1 nM dasatinib or 10 nM saracatinib treatment on PBF-repressed RAIU in MCF-7 (i) and MDA-MB-231 (ii) cells transiently co-transfected with NIS-MYC. <em>n</em> = 3 for all experiments. Error bars = SEM. * = <em>P</em> &lt; 0.05, ** = <em>P</em> &lt; 0.01, *** = <em>P</em> &lt; 0.001.</p></figcaption></figure><p>Having confirmed the effectiveness of SKF inhibition at restoring PBF-repressed RAIU in breast cancer cells, we investigated alternative SFK inhibitors to identify a compound that most potently inhibits PBF phosphorylation and therefore has the potential to maximise RAI therapy in both breast and thyroid cancer patients. We selected two SFK inhibitors which target Src with an IC50 &lt;5 nM and are either used clinically or are progressing through clinical trials. MCF-7 and MDA-MB-231 cells were treated with dasatinib and saracatinib at concentrations ranging from 1 nM to 2 μM for 24 h. Dasatinib virtually abolished PBF-pY174 levels at doses starting at 1 nM in both cell lines (<a href="#fig2" class="usa-link">Fig. 2D</a>), with saracatinib showing consistent results, albeit at slightly higher doses (Supplementary Fig. 3). Both dasatinib and saracatinib restored RAIU in cells transfected with NIS-MYC and PBF to levels comparable with NIS-MYC and VO co-expression in MCF-7 and MDA-MB-231 cells (<a href="#fig2" class="usa-link">Fig. 2E</a>).</p>
<p>Thus, SFK inhibition can overcome PBF repression of RAIU in breast cancer cells and dasatinib was identified as a potent inhibitor of PBF phosphorylation.</p></section><section id="sec3-3"><h3 class="pmc_sec_title">Dasatinib targets Src to restore PBF-mediated RAIU repression</h3>
<p>Although a potent SFK inhibitor, dasatinib can also target multiple other kinases (<a href="#bib30" class="usa-link" aria-describedby="bib30">30</a>). To further investigate a role for Src in modulating RAIU in breast cancer cells, we first overexpressed Src in MCF-7 and MDA-MB-231 cells and observed a marked increase in PBF-pY174 expression (<a href="#fig3" class="usa-link">Fig. 3A</a>). ATRA/Dex-treated MCF-7 cells stably transfected with VO, PBF-WT, PBF-EEN- MUT or PBF-Y174A were then transiently transfected with Src or VO control. Stable PBF-WT expression significantly reduced RAIU compared with VO-transfected cells, while neither PBF-EEN-MUT nor PBF-Y174A had any marked effect (<a href="#fig3" class="usa-link">Fig. 3B</a>). Interestingly, exogenous Src significantly reduced RAIU across each of the stable cell lines compared with VO-transfected cells with the exception of PBF-EEN-MUT (<a href="#fig3" class="usa-link">Fig. 3B</a>). Moreover, PBF and Src co-transfection resulted in an additive effect with a significant decrease in RAIU compared with PBF (↓33% compared with PBF + VO, <em>P</em> = 0.045) or Src (↓42% compared with VO + Src, <em>P</em> = 0.006) alone (<a href="#fig3" class="usa-link">Fig. 3B</a>).</p>
<figure class="fig xbox font-sm" id="fig3"><h4 class="obj_head">Figure 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372067_ERC-24-0312fig3.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b460/12372067/701f518ef6e2/ERC-24-0312fig3.jpg" loading="lazy" height="945" width="723" alt="Figure 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig3/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(A) Detection of PBF and PBF-pY174 levels following Src overexpression for 48 h in MCF-7 and MDA-MB-231 cells. (B) RAIU in ATRA/Dex-treated MCF-7 cells with stable expression of VO, PBF-WT, PBF-EEN-MUT or PBF-Y174A following transient transfection with Src or VO control. (C) Expression levels of PBF and PBF-pY174 in MCF-7 cells transiently transfected for 48 h with VO, Src-WT or the gatekeeper mutant Src-T341I and treated for 24 h with either DMSO or 10 nM dasatinib. (D) RAIU in ATRA/Dex-treated MCF-7 cells stably transfected with VO and PBF, transiently transfected with VO, Src-WT or Src-T341I for 48 h and treated with either DMSO or 10 nM dasatinib for 24 h. (E) Example of a heterozygous mutation induced by CRISPR-Cas9 targeting to PBF exon 1 in the MCF-7 PBF-KO #1 clonal cell line. (F) Confirmation of PBF deletion by Western blotting in MCF-7 and MDA-MB-231 PBF-KO cells generated using gRNA#1 (PBF-KO #1) and gRNA#2 (PBF-KO #2). (G) RAIU in parental MCF-7 cells and two PBF knockout cell lines (PBF-KO #1 and #2) following NIS, Src and NIS + Src overexpression. Confirmation of successful transfection shown below by Western blotting. (H and I) RAIU in parental MDA-MB-231 cells and PBF-KO cell lines (PBF-KO #1 and #2) following NIS, Src and NIS + Src overexpression. Confirmation of successful transfection shown below by Western blotting (J). <em>n</em> = 3 for all experiments. Error bars = SEM. Significance shown compared with VO unless otherwise shown. ns = not significant (<em>P</em> &gt; 0.05), * = <em>P</em> &lt; 0.05, ** = <em>P</em> &lt; 0.01, *** = <em>P</em> &lt; 0.001.</p></figcaption></figure><p>To specifically evaluate Src in SFK inhibitor restoration of RAIU, we utilised the Src-T341I gatekeeper mutant, which is resistant to dasatinib. MCF-7 cells were transiently transfected with VO, Src-WT or Src-T341I and treated with either DMSO or 10 nM dasatinib. Dasatinib treatment abrogated levels of active Src-pY418 in Src-WT-expressing cells, whereas cells expressing mutant Src-T341I maintained Src-pY418 levels, confirming drug resistance (<a href="#fig3" class="usa-link">Fig. 3C</a>). The induction of PBF-pY174 levels by exogenous Src-WT was abrogated in the presence of dasatinib (<a href="#fig3" class="usa-link">Fig. 3C</a>). In contrast, while mutant Src-T341I also markedly increased levels of PBF-pY174, this induction was unaltered by dasatinib (<a href="#fig3" class="usa-link">Fig. 3C</a>).</p>
<p>To assess endogenous RAIU, ATRA/Dex-treated MCF-7 cells stably transfected with VO and PBF were transiently transfected with VO, Src-WT or Src-T341I and treated with either DMSO or 10 nM dasatinib (<a href="#fig3" class="usa-link">Fig. 3D</a>). Notably, in the presence of Src-T341I, dasatinib was unable to overcome Src’s influence on RAIU (<a href="#fig3" class="usa-link">Fig. 3D</a>).</p>
<p>These data strongly suggest that Src is the kinase responsible for PBF phosphorylation and subsequent repression of NIS function, and that dasatinib specifically targets Src to restore PBF-pY174-repressed RAIU.</p></section><section id="sec3-4"><h3 class="pmc_sec_title">Src overexpression represses RAIU in breast and thyroid cancer cells via PBF</h3>
<p>Src overexpression significantly repressed RAIU and enhanced PBF repression in breast cells (<a href="#fig3" class="usa-link">Fig. 3B</a>). To determine whether Src can modulate NIS function independently of PBF, we generated breast cancer cell lines with CRISPR-Cas9-mediated PBF deletion (<a href="#fig3" class="usa-link">Fig. 3E and F</a>; Supplementary Fig. 1). Src overexpression significantly repressed RAIU in parental MCF-7 cells transiently transfected with NIS (30%, <em>P</em> &lt; 0.001) (<a href="#fig3" class="usa-link">Fig. 3G and H</a>). In contrast, two PBF-knockout (PBF-KO) cell lines generated using different guide RNAs did not respond to Src overexpression (<a href="#fig3" class="usa-link">Fig. 3G and H</a>). Likewise, Src overexpression resulted in a significant reduction in RAIU in parental MDA-MB-231 cells (36%, <em>P</em> &lt; 0.001) but not in cells lacking PBF expression (<a href="#fig3" class="usa-link">Fig. 3I and J</a>). RAIU was similarly repressed by Src in parental TPC-1 thyroid cancer cells but not CRISPR-Cas9 PBF-KO TPC-1 cells (19%, <em>P</em> &lt; 0.001) (Supplementary Figs 1 and 4). Overall, these data demonstrate that Src overexpression represses NIS function in both breast and thyroid cancer cells in a manner entirely dependent upon PBF.</p></section><section id="sec3-5"><h3 class="pmc_sec_title">Src myristoylation inhibition induces RAIU via PBF</h3>
<p>Src localisation and activity are mediated by N-myristoylation, the irreversible post-translational addition of a 14-carbon saturated fatty acid, myristate, to Src glycine residue 2 (<a href="#bib31" class="usa-link" aria-describedby="bib31">31</a>). Src myristoylation is catalysed by the N-myristoyltransferase NMT1 (<a href="#bib32" class="usa-link" aria-describedby="bib32">32</a>). To determine whether RAIU could be modified through targeting Src myristoylation, we employed an NMT inhibitor (DDD85646; NMTi). Both breast and thyroid cancer cells were treated with varying NMTi doses (0–1 μM). All cell lines showed a significant dose-dependent increase in RAIU, with maximal induction at 1 μM NMTi (MCF-7 ↑47%, <em>P</em> = 0.003; MDA-MB-231 ↑88%, <em>P</em> &lt; 0.001; TPC-1 ↑67%, <em>P</em> = 0.036) (<a href="#fig4" class="usa-link">Fig. 4A</a>).</p>
<figure class="fig xbox font-sm" id="fig4"><h4 class="obj_head">Figure 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372067_ERC-24-0312fig4.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b460/12372067/0e3b5f47e55c/ERC-24-0312fig4.jpg" loading="lazy" height="941" width="755" alt="Figure 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig4/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>(A) RAIU in MCF-7 and MDA-MB-231 breast cancer cells and TPC-1 thyroid cancer cells transfected with NIS-MYC for 48 h and treated with varying doses of an NMT inhibitor (NMTi; 0–1 μM). The breast cancer cells were treated with NMTi for 4 h before RAIU and thyroid cancer cells were treated for 24 h. (B) RAIU in TPC-1 cells with stable NIS expression transfected with Src siRNA (or scrambled control) for 24 h before treatment with 1 μM NMTi (or DMSO vehicle control) for a further 24 h. (C) RAIU in parental MCF-7 (i), MDA-MB-231 (ii) and TPC-1 (iii) cells and two corresponding PBF knockout cell lines (PBF-KO #1 and #2) for each following VO or NIS transfection (48 h) and DMSO or 1 μM NMTi treatment (4 h – MCF-7/MDA-MB-231; 24 h – TPC-1). (D) TPC-1 cells were transfected with NIS-MYC for 48 h and then treated with DMSO, 1 nM dasatinib, 1 μM NMTi or a combination of the two drugs for 24 h before RAIU. (E) Schematic showing the NMT1/Src/PBF/NIS pathway. NMT1 myristoylates Src (1) and facilitates Src PM localisation and activation, resulting in PBF phosphorylation at Y174 (2). Phospho-PBF binds to NIS at the PM (3) leading to NIS internalisation and reduced RAIU (4). NMT1 inhibition (5) and Src inhibition (6) prevent PBF phosphorylation and NIS repression, while ATRA/Dex induces NIS expression and RAIU (7). <em>n</em> = 3 for all experiments. Error bars = SEM. Significance shown compared with VO and/or DMSO control unless otherwise shown. ns = not significant (<em>P</em> &gt; 0.05), * = <em>P</em> &lt; 0.05, ** = <em>P</em> &lt; 0.01, *** = <em>P</em> &lt; 0.001.</p></figcaption></figure><p>We next assessed whether NMTi induced RAIU specifically through Src myristoylation inhibition. In TPC-1 cells with stable NIS expression, NMTi induced RAIU by 99% (scrambled control (Scr) + NMTi vs Scr + DMSO, <em>P</em> = 0.002). However, following siRNA-mediated Src knockdown, NMTi treatment was unable to stimulate RAIU (Src siRNA + NMTi vs Scr + DMSO, <em>P</em> = 0.308) (<a href="#fig4" class="usa-link">Fig. 4B</a>).</p>
<p>To determine whether NMTi induction of RAIU was dependent upon PBF, we utilised the PBF-KO cell lines. Basal RAIU in parental MCF-7 cells was not stimulated by NMTi (<a href="#fig4" class="usa-link">Fig. 4C(i)</a>) or dasatinib treatment (Supplementary Fig. 5A), further suggesting that these drugs influence NIS post-translationally. However, NMTi treatment resulted in a 29% increase in RAIU via exogenous NIS (<em>P</em> = 0.018) (<a href="#fig4" class="usa-link">Fig. 4C(i)</a>). In contrast, neither of the two MCF-7 PBF-KO cell lines responded to NMTi. Similarly, PBF was required for NMTi induction of MDA-MB-231 and TPC-1 cells as evidenced by the loss of response in all PBF-KO lines tested (<a href="#fig4" class="usa-link">Fig. 4C(ii–iii)</a>).</p>
<p>Given that Src therefore mediates NMTi induction of RAIU, we looked to further boost this effect through combination treatment of 1 μM NMTi and 1 nM dasatinib. However, dasatinib treatment did not further induce the NMTi-mediated increase in RAIU via exogenous NIS in any of the cell lines (<a href="#fig4" class="usa-link">Fig. 4D</a> and Supplementary Fig. 5B and C). Similarly, although NMTi significantly induced ATRA/Dex-stimulated RAIU in MCF-7 cells, dasatinib treatment did not have an additive effect (Supplementary Fig. 5D), indicating that these inhibitors are targeting different parts of the same pathway (<a href="#fig4" class="usa-link">Fig. 4E</a>).</p>
<p>Overall, these data show that NMT inhibition significantly induces RAIU in both breast and thyroid cancer cell lines. Src myristoylation inhibition mediates this effect, which is dependent upon PBF. These studies therefore identify a new class of drugs that induce RAIU <em>in vitro</em> through acting on NMT1 to inhibit Src-mediated PBF phosphorylation (<a href="#fig4" class="usa-link">Fig. 4E</a>).</p></section><section id="sec3-6"><h3 class="pmc_sec_title">NMT1 and Src expression are associated with recurrence in RAI-treated thyroid cancer</h3>
<p>Given the availability of clinical data regarding radioiodide treatment, we first investigated NMT1, Src and PBF expression in thyroid cancer using The Cancer Genome Atlas (TCGA) and GEO datasets. NMT1, PBF and Src were all significantly upregulated in the TCGA PTC (THCA) cohort (Supplementary Fig. 6A) and in an independent GEO PTC dataset <a href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE60542" class="usa-link" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">GSE60542</a> (Supplementary Fig. 6B). PBF and Src were highly expressed in the more aggressive BRAF-like PTC in comparison with RAS-like PTC and demonstrated a significant positive correlation in the entire PTC cohort (Supplementary Fig. 6C and D). In addition, increasing levels of NMT1 and Src expression were seen in PDTC and ATC, which had concomitantly lower levels of NIS expression (Supplementary Fig. 6E) (<a href="#bib28" class="usa-link" aria-describedby="bib28">28</a>). Of particular significance, NMT1 expression, in contrast to Src, was elevated in recurrent BRAF-like PTC treated with RAI, with ROC analysis indicating that high tumoural NMT1 might be a good predictor of recurrence (AUC = 0.734; Supplementary Fig. 6F).</p>
<p>Indeed, higher NMT1 and Src expression were associated with a significant reduction in DFS in RAI-treated PTC but not in non-RAI-treated PTC (Supplementary Fig. 7A, B, C). Cox regression analysis revealed that high tumoural NMT1 and Src were associated with an increased risk of recurrence in most subgroups except non-RAI-treated PTC (Supplementary Fig. 7D and E). Importantly, only RAI-treated PTC patients with high tumoural NMT1 and Src expression had significantly lower DFS compared with those with low NMT1 and Src expression (Supplementary Fig. 7F, G, H). RAI-treated PTC patients with low NIS expression in addition to high NMT1 or Src expression had the shortest DFS. However, DFS in patients with low NIS and high NMT1/Src was ∼40% lower than those with low NMT1/Src regardless of NIS expression (Supplementary Fig. 7I, J, K).</p>
<p>Overall, bioinformatic TCGA analyses demonstrated a strong association between high NMT1 and Src expression, increased recurrence risk and decreased DFS in PTC. The strength of these associations in RAI-treated patients may suggest a contribution to poorer therapeutic response.</p></section><section id="sec3-7"><h3 class="pmc_sec_title">Association between high PBF and Src expression and more aggressive breast cancers</h3>
<p>We next appraised the TCGA breast cancer (BRCA) dataset. Both PBF and Src expression were significantly upregulated in most BRCA histotypes and in all forms stratified by hormone status (oestrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2); <a href="#fig5" class="usa-link">Fig. 5A and B</a>). Importantly, PBF and Src were most highly expressed in the more aggressive HER2-positive (ER<sup>−</sup>/PR<sup>−</sup>/HER2<sup>+</sup>) and TNBC (ER<sup>−</sup>/PR<sup>−</sup>/HER2<sup>−</sup>) tumours, which were associated with a significantly lower DFS compared with the ER<sup>+</sup> and/or PR<sup>+</sup> luminal cancers (Supplementary Fig. 8A). In contrast to THCA, NMT1 expression in the BRCA cohort was lower compared with normal breast tissue (<a href="#fig5" class="usa-link">Fig. 5C</a>), although overall NMT1 expression levels were similar to thyroidal expression (<a href="#fig5" class="usa-link">Fig. 5</a> and Supplementary Fig. 6). NIS expression was also significantly upregulated in several histotypes, predominantly in the breast invasive ductal carcinoma (BIDC) and within all molecular subtypes (<a href="#fig5" class="usa-link">Fig. 5D</a>).</p>
<figure class="fig xbox font-sm" id="fig5"><h4 class="obj_head">Figure 5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=12372067_ERC-24-0312fig5.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b460/12372067/cc9b5c75371c/ERC-24-0312fig5.jpg" loading="lazy" height="699" width="686" alt="Figure 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/fig5/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Elevated PBF and SRC expression in breast cancer. Box and whisker plots showing expression (log<sub>2</sub>) of PBF (A), SRC (B), NMT1 (C) and NIS (D) in various histotypes and molecular subtypes of the TGCA breast cancer (BRCA) RNA-Seq dataset versus normal (<em>N</em>; <em>n</em> = 112). BIDC = breast invasive ductal carcinoma (<em>n</em> = 812); BILC = breast invasive lobular carcinoma (<em>n</em> = 206); BIMMC = breast invasive mixed mucinous carcinoma (<em>n</em> = 16); BMDLC = breast mixed ductal and lobular carcinoma (<em>n</em> = 28); IBC = invasive breast carcinoma (<em>n</em> = 6); MBC = metaplastic breast cancer (<em>n</em> = 14); PDN = Paget’s disease of the nipple (<em>n</em> = 3); Luminal (ER<sup>+</sup> and/or PR<sup>+</sup>; <em>n</em> = 565); HER2 = HER2-positive (<em>n</em> = 37); TNBC = triple negative breast cancer (<em>n</em> = 114). (E) <em>Left</em> – Box and whisker plots showing SRC and PBF expression in the BRCA cohort stratified by high versus low tumoural PBF/SRC expression in combination. <em>Right</em> – Correlation between those with high versus low tumoural PBF/SRC expression (<em>n</em> = 404/660). (F) <em>Left</em> – Proportion of molecular subtypes (%) within tumours with high versus low expression of both SRC and PBF. <em>Right</em> – Kaplan–Meier analysis of overall survival for BRCA patients with high versus low tumoural SRC and PBF expression. Number (<em>n</em>) of patients per sub-group. <em>P</em><sub>L</sub> = log-rank test; <em>P</em><sub>B</sub> = Breslow test. ns = not significant; ** = <em>P</em> &lt; 0.01; *** = <em>P</em> &lt; 0.001.</p></figcaption></figure><p>Critically, stratification of patient groups identified a strong correlation between those with high versus low tumoural PBF and Src expression in combination (<a href="#fig5" class="usa-link">Fig. 5E</a>, 404/660 BRCA patients). Of particular significance, patients with high PBF/Src expression had a significantly higher proportion of HER2-positive and TNBC tumours than those with low PBF/Src expression (<a href="#fig5" class="usa-link">Fig. 5F</a>), which was reflected in greater reduction in overall survival (<a href="#fig5" class="usa-link">Fig. 5G</a>) compared to other patient groups (Supplementary Fig. 8B). These findings indicate that PBF and Src are both associated with poorer survival characteristics in BRCA patients and represent promising new drug targets in patients who typically have aggressive disease and would benefit most from targeted enhancement of RAI therapy.</p></section></section><section id="sec4"><h2 class="pmc_sec_title">Discussion</h2>
<p>A major barrier to RAI utilisation as a potential breast cancer therapy is the lack of understanding of how NIS is trafficked within breast cancer cells. While NIS PM localisation is fundamental for RAIU, its regulation remains to be fully elucidated. Broadly, TSH promotes thyroidal NIS membrane localisation while the BRAF<sup>V600E</sup> oncogene impedes it (<a href="#bib11" class="usa-link" aria-describedby="bib11">11</a>). Mass spectrometry-based interaction studies have been instrumental in identifying NIS interactors, such as valosin-containing protein (VCP), ADP ribosylation factor 4 (ARF4) (<a href="#bib20" class="usa-link" aria-describedby="bib20">20</a>), Rac family small GTPase 1 (RAC1) and ezrin (<a href="#bib17" class="usa-link" aria-describedby="bib17">17</a>). These studies demonstrate that cellular processes such as endoplasmic reticulum-associated degradation (ERAD) (<a href="#bib20" class="usa-link" aria-describedby="bib20">20</a>), endocytosis (<a href="#bib12" class="usa-link" aria-describedby="bib12">12</a>), actin cytoskeleton regulation (<a href="#bib17" class="usa-link" aria-describedby="bib17">17</a>) and cell–cell adhesion (<a href="#bib18" class="usa-link" aria-describedby="bib18">18</a>) govern NIS trafficking and PM retention. Furthermore, examples of universal NIS trafficking mechanisms, e.g. ARF4 and VCP regulation, exist in both breast and thyroid cancer cells (<a href="#bib20" class="usa-link" aria-describedby="bib20">20</a>).</p>
<p>PBF was the first NIS-interacting protein identified as a modulator of NIS subcellular localisation (<a href="#bib13" class="usa-link" aria-describedby="bib13">13</a>). Through NIS internalisation, PBF is a potent repressor of RAIU in thyroid cancer cells (<a href="#bib13" class="usa-link" aria-describedby="bib13">13</a>, <a href="#bib16" class="usa-link" aria-describedby="bib16">16</a>), and we now show that PBF can also bind and repress NIS in breast cancer cells. Although PBF-Y174 is known to mediate the NIS/PBF interaction, putative binding sites on NIS, such as the PDZ-binding motif that is required for NIS PM localisation, are yet to be established (<a href="#bib16" class="usa-link" aria-describedby="bib16">16</a>, <a href="#bib33" class="usa-link" aria-describedby="bib33">33</a>). Furthermore, we identified the SFK inhibitors saracatinib and dasatinib as potent PBF-pY174 inhibitors capable of reversing PBF-mediated NIS repression in breast cancer cells. Notably, Src overexpression significantly repressed RAIU and enhanced PBF repression of NIS, highlighting the substantial contribution of Src in modulating NIS.</p>
<p>To explore an alternative method of inhibiting Src, we targeted Src N-myristoylation, a key post-translational modification. NMT1-mediated attachment of myristate to the N-terminal end of Src is required for its membrane association and NMT1 inhibition/knockdown decreases Src activity (<a href="#bib32" class="usa-link" aria-describedby="bib32">32</a>, <a href="#bib34" class="usa-link" aria-describedby="bib34">34</a>, <a href="#bib35" class="usa-link" aria-describedby="bib35">35</a>, <a href="#bib36" class="usa-link" aria-describedby="bib36">36</a>). Here, we demonstrated a dose-dependent NMTi induction of RAIU via exogenous NIS in both breast and thyroid cancer cells. Importantly, as ∼3% proteins are myristoylated (<a href="#bib37" class="usa-link" aria-describedby="bib37">37</a>), we used siRNA-mediated knockdown to confirm that NMTi-induced RAIU is Src-dependent. In addition, combinatorial NMTi and dasatinib treatment did not have an additive effect, suggesting that both induce RAIU via Src inhibition within the same pathway. Finally, the dependency of NMTi-induced RAIU on PBF was demonstrated using CRISPR-Cas9 PBF-knockout cell lines. Overall, these studies strongly suggest that Src represses RAIU through post-translational NIS modulation in a manner dependent on Src myristoylation and kinase activity, and through PBF phosphorylation.</p>
<p>Recently, another group verified our association between Src and NIS PM localisation following the identification of Src as a potential NIS interactor through mass spectrometry (<a href="#bib17" class="usa-link" aria-describedby="bib17">17</a>, <a href="#bib18" class="usa-link" aria-describedby="bib18">18</a>). However, in contrast to our studies, Faria <em>et al</em> proposed that Src induces NIS PM localisation through activating the small GTPase RAC1. RAC1 signalling via p21-activated kinase 1 (PAK1) and phosphatidylinositol-4-phosphate-5-kinase (PIP5K)-induced ARP2/3-mediated actin polymerisation and recruitment of another NIS interactor, ezrin (<a href="#bib17" class="usa-link" aria-describedby="bib17">17</a>). While a clear interaction between Src and NIS was demonstrated, Src induction of RAIU was determined by treatment with PP2, which is a non-selective SFK inhibitor (<a href="#bib38" class="usa-link" aria-describedby="bib38">38</a>), and may therefore inhibit RAC1 signalling via other targets. However, both opposing pathways may be operational in cancer cells and further mechanistic investigations are required. Importantly, we have now shown that Src overexpression inhibits RAIU in multiple cell lines, and that several Src inhibitors, with different mechanisms of action, induce RAIU. In demonstrating a role for the Src substrate PBF in Src-mediated repression of RAIU, and its subsequent pharmacological restoration, these studies indicate a negative effect of Src on RAIU.</p>
<p>In order to relate these findings to clinical outcomes, we first performed a comprehensive analysis of TCGA and GEO thyroid cancer gene expression datasets, alongside PDTC and ATC datasets (<a href="#bib28" class="usa-link" aria-describedby="bib28">28</a>). We observed a strong association between high NMT1 and Src expression, more aggressive tumours, increased recurrence risk and decreased DFS in PTC. An association between increased Src expression/activity and thyroid tumour aggressiveness is well-established, with Src inhibition reducing thyroid cancer cell proliferation and invasiveness <em>in vitro</em> and tumour growth and metastasis <em>in vivo</em> (<a href="#bib39" class="usa-link" aria-describedby="bib39">39</a>, <a href="#bib40" class="usa-link" aria-describedby="bib40">40</a>, <a href="#bib41" class="usa-link" aria-describedby="bib41">41</a>, <a href="#bib42" class="usa-link" aria-describedby="bib42">42</a>, <a href="#bib43" class="usa-link" aria-describedby="bib43">43</a>, <a href="#bib44" class="usa-link" aria-describedby="bib44">44</a>). While combined Src and MAPK pathway inhibitors are effective in both <em>in vitro</em> and pre-clinical studies (<a href="#bib45" class="usa-link" aria-describedby="bib45">45</a>, <a href="#bib46" class="usa-link" aria-describedby="bib46">46</a>, <a href="#bib47" class="usa-link" aria-describedby="bib47">47</a>), kinase inhibitor resistance is likely to limit clinical utility. Src inhibitor resistance is mediated by both MAPK and PI3K signalling pathway activation (<a href="#bib46" class="usa-link" aria-describedby="bib46">46</a>, <a href="#bib47" class="usa-link" aria-describedby="bib47">47</a>, <a href="#bib48" class="usa-link" aria-describedby="bib48">48</a>). However, combination therapy of Src, MAPK and PI3K inhibitors required to overcome resistance is likely to be too toxic in a clinical setting (<a href="#bib49" class="usa-link" aria-describedby="bib49">49</a>).</p>
<p>Increased NMT1 expression and activity is observed in multiple cancer types (<a href="#bib31" class="usa-link" aria-describedby="bib31">31</a>). Association with poor outcomes is considered to be due to aberrant Src activation, leading to increased cancer cell metabolism, cancer metastasis and drug resistance, presenting NMT1 as a potential therapeutic target (<a href="#bib31" class="usa-link" aria-describedby="bib31">31</a>). To our knowledge, this is the first report of NMT1 upregulation in thyroid cancer and we propose that high NMT1 expression predicts recurrence. High levels of both NMT1 and Src expression were associated with decreased DFS in RAI-treated patients, implying contribution to thyroid tumour progression. Analysis of the TCGA breast cancer cohort showed that NMT1 mRNA expression was reduced compared with normal tissue, although expression levels remained comparable with thyroidal NMT1. In contrast, a recent study showed that NMT1 is highly expressed in breast cancer and associated with aggressiveness (<a href="#bib50" class="usa-link" aria-describedby="bib50">50</a>). Furthermore, treatment with a pan-NMT inhibitor, PCLX-001, decreased breast cancer cell viability <em>in vitro</em> and led to a dose-dependent reduction in the growth of MDA-MB-231 breast cancer xenografts, demonstrating significant NMT1 activity and supporting potential clinical utility in breast cancer (<a href="#bib50" class="usa-link" aria-describedby="bib50">50</a>).</p>
<p>In the TCGA breast cancer cohort, there was a broad upregulation of PBF and Src across most tumour types. PBF is upregulated in breast tumours and a strong correlation exists between the number of repeat oestrogen-responsive elements (EREs) in the PBF promoter, PBF expression and breast cancer risk (<a href="#bib19" class="usa-link" aria-describedby="bib19">19</a>, <a href="#bib51" class="usa-link" aria-describedby="bib51">51</a>). PBF also induces breast cancer cell migration and invasion (<a href="#bib19" class="usa-link" aria-describedby="bib19">19</a>, <a href="#bib52" class="usa-link" aria-describedby="bib52">52</a>). Oncogenic Src overexpression and/or activation in breast cancer co-ordinates signal transduction between multiple membrane proteins and downstream targets to drive cell growth, survival, migration, invasion and, ultimately, tumour progression (<a href="#bib53" class="usa-link" aria-describedby="bib53">53</a>). Importantly, this study highlighted an association between high PBF and Src expression, HER2-positive and TNBC tumours, and decreased survival. Thus, in the most aggressive, difficult-to-treat breast tumours, which require alternative therapeutic options, targeting Src and PBF will likely be critical for efficacious RAI therapy.</p>
<p>As shown in multiple other studies (<a href="#bib54" class="usa-link" aria-describedby="bib54">54</a>), NIS expression was significantly upregulated in the TCGA breast cancers. Given the heterogeneous level of expression, it is likely that combinatorial treatment inducing both NIS expression and PM localisation will be most efficacious in breast cancer. Short-term enhancement of endogenous NIS expression in breast cancer cells using ATRA/Dex (<a href="#bib29" class="usa-link" aria-describedby="bib29">29</a>, <a href="#bib55" class="usa-link" aria-describedby="bib55">55</a>) or HDAC inhibitors (<a href="#bib56" class="usa-link" aria-describedby="bib56">56</a>, <a href="#bib57" class="usa-link" aria-describedby="bib57">57</a>, <a href="#bib58" class="usa-link" aria-describedby="bib58">58</a>) with induction of PM NIS through NMT1/Src inhibition to cooperatively promote NIS function before giving RAI represents a promising treatment option that would overcome potential toxicity issues with long-term administration of these and other drugs. Of note, the inherent ability of the thyroid to avidly accumulate iodide would both hinder effective RAI targeting to breast tumours and potentially result in thyroidal damage, leading to hypothyroidism and increased risk of thyroid cancer. However, thyroidal uptake and accumulation of RAI can be selectively blocked using liothyronine (T3) to suppress TSH, resulting in reduced thyroidal NIS expression and function, and methimazole (MMI) to inhibit thyroid peroxidase (TPO) and prevent iodide organification (<a href="#bib7" class="usa-link" aria-describedby="bib7">7</a>). Therefore, pre-treatment with T3/MMI before RAI therapy would both avoid potential thyroid damage and maximise RAI availability to target breast tumours (<a href="#bib7" class="usa-link" aria-describedby="bib7">7</a>).</p>
<p>Overall, these studies have shown that PBF repression of NIS function can be modulated by Src and that RAIU may be enhanced through inhibiting Src myristoylation by NMT1. High expression of NMT1 and Src are associated with thyroid tumour recurrence and PBF and Src are highly expressed in breast cancer, particularly in more aggressive forms. Therefore, in advanced tumours that may benefit from alternative therapies, targeting NIS repression by Src and PBF through NMT1 inhibition may be a viable approach for augmenting RAI-avidity in breast cancer.</p></section><section id="supp1"><h2 class="pmc_sec_title">Supplementary materials</h2>
<section class="sm xbox font-sm" id="SD1"><div class="media p" id="d67e1168"><div class="caption">
<a href="/articles/instance/12372067/bin/supplementary_materials.pdf" data-ga-action="click_feat_suppl" class="usa-link">supplementary_materials.pdf</a><sup> (596.9KB, pdf) </sup>
</div></div></section></section><section id="sec24"><h2 class="pmc_sec_title">Declaration of interest</h2>
<p>The authors declare that there is no conflict of interest that could be perceived as prejudicing the impartiality of the work reported.</p></section><section id="sec25"><h2 class="pmc_sec_title">Funding</h2>
<p>This work was supported by the Medical Research Council (MRC Doctoral Training Grant), the Government of Saudi Arabia (Scholarship NJU161) and the Department of Defense (grant number BC201532P1).</p></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>We thank the Drug Discovery Unit (University of Dundee) for the provision of the NMT inhibitor (DDD00085646).</p></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="bib1">
<span class="label">1.</span><cite>Buffet C, Wassermann J, Hecht F, et al. 
Redifferentiation of radioiodine-refractory thyroid cancers. Endocr Relat Cancer
2020. 
27
R113–R132. ( 10.1530/erc-19-0491)
</cite> [<a href="https://doi.org/10.1530/erc-19-0491" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32191916/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Endocr%20Relat%20Cancer&amp;title=Redifferentiation%20of%20radioiodine-refractory%20thyroid%20cancers&amp;volume=27&amp;publication_year=2020&amp;pages=R113-R132&amp;pmid=32191916&amp;doi=10.1530/erc-19-0491&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib2">
<span class="label">2.</span><cite>Spitzweg C, Nelson PJ, Wagner E, et al. The sodium iodide symporter (NIS): novel applications for radionuclide imaging and treatment. Endocr Relat Cancer
2021. 
28
T193–T213. ( 10.1530/erc-21-0177)
</cite> [<a href="https://doi.org/10.1530/erc-21-0177" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34259647/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Endocr%20Relat%20Cancer&amp;title=The%20sodium%20iodide%20symporter%20(NIS):%20novel%20applications%20for%20radionuclide%20imaging%20and%20treatment&amp;volume=28&amp;publication_year=2021&amp;pages=T193-T213&amp;pmid=34259647&amp;doi=10.1530/erc-21-0177&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib3">
<span class="label">3.</span><cite>Tazebay UH, Wapnir IL, Levy O, et al. 
The mammary gland iodide transporter is expressed during lactation and in breast cancer. Nat Med
2000. 
6
871–878. ( 10.1038/78630)
</cite> [<a href="https://doi.org/10.1038/78630" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10932223/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Med&amp;title=The%20mammary%20gland%20iodide%20transporter%20is%20expressed%20during%20lactation%20and%20in%20breast%20cancer&amp;volume=6&amp;publication_year=2000&amp;pages=871-878&amp;pmid=10932223&amp;doi=10.1038/78630&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib4">
<span class="label">4.</span><cite>Wapnir IL, van de Rijn M, Nowels K, et al. 
Immunohistochemical profile of the sodium/iodide symporter in thyroid, breast, and other carcinomas using high density tissue microarrays and conventional sections. J Clin Endocrinol Metab
2003. 
88
1880–1888. ( 10.1210/jc.2002-021544)
</cite> [<a href="https://doi.org/10.1210/jc.2002-021544" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/12679487/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Endocrinol%20Metab&amp;title=Immunohistochemical%20profile%20of%20the%20sodium/iodide%20symporter%20in%20thyroid,%20breast,%20and%20other%20carcinomas%20using%20high%20density%20tissue%20microarrays%20and%20conventional%20sections&amp;volume=88&amp;publication_year=2003&amp;pages=1880-1888&amp;pmid=12679487&amp;doi=10.1210/jc.2002-021544&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib5">
<span class="label">5.</span><cite>Knostman KA, McCubrey JA, Morrison CD, et al. 
PI3K activation is associated with intracellular sodium/iodide symporter protein expression in breast cancer. BMC Cancer
2007. 
7
137. ( 10.1186/1471-2407-7-137)
</cite> [<a href="https://doi.org/10.1186/1471-2407-7-137" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC1963336/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17651485/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=BMC%20Cancer&amp;title=PI3K%20activation%20is%20associated%20with%20intracellular%20sodium/iodide%20symporter%20protein%20expression%20in%20breast%20cancer&amp;volume=7&amp;publication_year=2007&amp;pages=137&amp;pmid=17651485&amp;doi=10.1186/1471-2407-7-137&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib6">
<span class="label">6.</span><cite>Renier C, Yao C, Goris M, et al. 
Endogenous NIS expression in triple-negative breast cancers. Ann Surg Oncol
2009. 
16
962–968. ( 10.1245/s10434-008-0280-9)
</cite> [<a href="https://doi.org/10.1245/s10434-008-0280-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19184238/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann%20Surg%20Oncol&amp;title=Endogenous%20NIS%20expression%20in%20triple-negative%20breast%20cancers&amp;volume=16&amp;publication_year=2009&amp;pages=962-968&amp;pmid=19184238&amp;doi=10.1245/s10434-008-0280-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib7">
<span class="label">7.</span><cite>Wapnir IL, Goris M, Yudd A, et al. 
The Na+/I− symporter mediates iodide uptake in breast cancer metastases and can be selectively down-regulated in the thyroid. Clin Cancer Res
2004. 
10
4294–4302. ( 10.1158/1078-0432.ccr-04-0074)
</cite> [<a href="https://doi.org/10.1158/1078-0432.ccr-04-0074" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15240514/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Cancer%20Res&amp;title=The%20Na+/I%E2%88%92%20symporter%20mediates%20iodide%20uptake%20in%20breast%20cancer%20metastases%20and%20can%20be%20selectively%20down-regulated%20in%20the%20thyroid&amp;volume=10&amp;publication_year=2004&amp;pages=4294-4302&amp;pmid=15240514&amp;doi=10.1158/1078-0432.ccr-04-0074&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib8">
<span class="label">8.</span><cite>Renier C, Vogel H, Offor O, et al. 
Breast cancer brain metastases express the sodium iodide symporter. J Neuro Oncol
2010. 
96
331–336. ( 10.1007/s11060-009-9971-8)</cite> [<a href="https://doi.org/10.1007/s11060-009-9971-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19618116/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Neuro%20Oncol&amp;title=Breast%20cancer%20brain%20metastases%20express%20the%20sodium%20iodide%20symporter&amp;volume=96&amp;publication_year=2010&amp;pages=331-336&amp;pmid=19618116&amp;doi=10.1007/s11060-009-9971-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib9">
<span class="label">9.</span><cite>Moon DH, Lee SJ, Park KY, et al. 
Correlation between 99mTc-pertechnetate uptakes and expressions of human sodium iodide symporter gene in breast tumor tissues. Nucl Med Biol
2001. 
28
829–834. ( 10.1016/s0969-8051(01)00243-8)
</cite> [<a href="https://doi.org/10.1016/s0969-8051(01)00243-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11578905/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nucl%20Med%20Biol&amp;title=Correlation%20between%2099mTc-pertechnetate%20uptakes%20and%20expressions%20of%20human%20sodium%20iodide%20symporter%20gene%20in%20breast%20tumor%20tissues&amp;volume=28&amp;publication_year=2001&amp;pages=829-834&amp;pmid=11578905&amp;doi=10.1016/s0969-8051(01)00243-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib10">
<span class="label">10.</span><cite>Ravera S, Reyna-Neyra A, Ferrandino G, et al. 
The sodium/iodide symporter (NIS): molecular physiology and preclinical and clinical applications. Annu Rev Physiol
2017. 
79
261–289. ( 10.1146/annurev-physiol-022516-034125)
</cite> [<a href="https://doi.org/10.1146/annurev-physiol-022516-034125" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5739519/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28192058/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Annu%20Rev%20Physiol&amp;title=The%20sodium/iodide%20symporter%20(NIS):%20molecular%20physiology%20and%20preclinical%20and%20clinical%20applications&amp;volume=79&amp;publication_year=2017&amp;pages=261-289&amp;pmid=28192058&amp;doi=10.1146/annurev-physiol-022516-034125&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib11">
<span class="label">11.</span><cite>Carro GH &amp; Nicola JP. Molecular mechanisms underlying sodium iodide symporter expression at the plasma membrane in the thyroid follicular cell. Curr Opin Endocr Metab Res
2023. 
33
100492. ( 10.1016/j.coemr.2023.100492)</cite> [<a href="https://doi.org/10.1016/j.coemr.2023.100492" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Curr%20Opin%20Endocr%20Metab%20Res&amp;title=Molecular%20mechanisms%20underlying%20sodium%20iodide%20symporter%20expression%20at%20the%20plasma%20membrane%20in%20the%20thyroid%20follicular%20cell&amp;volume=33&amp;publication_year=2023&amp;pages=100492&amp;doi=10.1016/j.coemr.2023.100492&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib12">
<span class="label">12.</span><cite>Read ML, Brookes K, Zha L, et al. 
Combined vorinostat and chloroquine inhibit sodium-iodide symporter endocytosis and enhance radionuclide uptake in vivo. Clin Cancer Res
2024. 
30
1352–1366. ( 10.1158/1078-0432.ccr-23-2043)
</cite> [<a href="https://doi.org/10.1158/1078-0432.ccr-23-2043" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7615786/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37921808/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Cancer%20Res&amp;title=Combined%20vorinostat%20and%20chloroquine%20inhibit%20sodium-iodide%20symporter%20endocytosis%20and%20enhance%20radionuclide%20uptake%20in%20vivo&amp;volume=30&amp;publication_year=2024&amp;pages=1352-1366&amp;pmid=37921808&amp;doi=10.1158/1078-0432.ccr-23-2043&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib13">
<span class="label">13.</span><cite>Smith VE, Read ML, Turnell AS, et al. 
A novel mechanism of sodium iodide symporter repression in differentiated thyroid cancer. J Cell Sci
2009. 
122
3393–3402. ( 10.1242/jcs.045427)
</cite> [<a href="https://doi.org/10.1242/jcs.045427" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2736868/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19706688/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Cell%20Sci&amp;title=A%20novel%20mechanism%20of%20sodium%20iodide%20symporter%20repression%20in%20differentiated%20thyroid%20cancer&amp;volume=122&amp;publication_year=2009&amp;pages=3393-3402&amp;pmid=19706688&amp;doi=10.1242/jcs.045427&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib14">
<span class="label">14.</span><cite>Stratford AL, Boelaert K, Tannahill LA, et al. 
Pituitary tumor transforming gene binding factor: a novel transforming gene in thyroid tumorigenesis. J Clin Endocrinol Metab
2005. 
90
4341–4349. ( 10.1210/jc.2005-0523)
</cite> [<a href="https://doi.org/10.1210/jc.2005-0523" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15886233/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Endocrinol%20Metab&amp;title=Pituitary%20tumor%20transforming%20gene%20binding%20factor:%20a%20novel%20transforming%20gene%20in%20thyroid%20tumorigenesis&amp;volume=90&amp;publication_year=2005&amp;pages=4341-4349&amp;pmid=15886233&amp;doi=10.1210/jc.2005-0523&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib15">
<span class="label">15.</span><cite>Hsueh C, Lin JD, Chang YS, et al. 
Prognostic significance of pituitary tumour-transforming gene-binding factor (PBF) expression in papillary thyroid carcinoma. Clin Endocrinol
2013. 
78
303–309. ( 10.1111/cen.12007)</cite> [<a href="https://doi.org/10.1111/cen.12007" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22888961/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Endocrinol&amp;title=Prognostic%20significance%20of%20pituitary%20tumour-transforming%20gene-binding%20factor%20(PBF)%20expression%20in%20papillary%20thyroid%20carcinoma&amp;volume=78&amp;publication_year=2013&amp;pages=303-309&amp;pmid=22888961&amp;doi=10.1111/cen.12007&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib16">
<span class="label">16.</span><cite>Smith VE, Sharma N, Watkins RJ, et al. 
Manipulation of PBF/PTTG1IP phosphorylation status; a potential new therapeutic strategy for improving radioiodine uptake in thyroid and other tumors. J Clin Endocrinol Metab
2013. 
98
2876–2886. ( 10.1210/jc.2012-3640)
</cite> [<a href="https://doi.org/10.1210/jc.2012-3640" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4207948/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23678037/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Endocrinol%20Metab&amp;title=Manipulation%20of%20PBF/PTTG1IP%20phosphorylation%20status;%20a%20potential%20new%20therapeutic%20strategy%20for%20improving%20radioiodine%20uptake%20in%20thyroid%20and%20other%20tumors&amp;volume=98&amp;publication_year=2013&amp;pages=2876-2886&amp;pmid=23678037&amp;doi=10.1210/jc.2012-3640&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib17">
<span class="label">17.</span><cite>Faria M, Domingues R, Bugalho MJ, et al. 
Analysis of NIS plasma membrane interactors discloses key regulation by a SRC/RAC1/PAK1/PIP5K/EZRIN pathway with potential implications for radioiodine Re-Sensitization therapy in thyroid cancer. Cancers
2021. 
13
5460. ( 10.3390/cancers13215460)
</cite> [<a href="https://doi.org/10.3390/cancers13215460" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8582450/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34771624/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancers&amp;title=Analysis%20of%20NIS%20plasma%20membrane%20interactors%20discloses%20key%20regulation%20by%20a%20SRC/RAC1/PAK1/PIP5K/EZRIN%20pathway%20with%20potential%20implications%20for%20radioiodine%20Re-Sensitization%20therapy%20in%20thyroid%20cancer&amp;volume=13&amp;publication_year=2021&amp;pages=5460&amp;pmid=34771624&amp;doi=10.3390/cancers13215460&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib18">
<span class="label">18.</span><cite>Faria M, Vareda J, Miranda M, et al. 
Adherens junction integrity is a critical determinant of sodium iodide symporter residency at the plasma membrane of thyroid cells. Cancers
2022. 
14
5362. ( 10.3390/cancers14215362)
</cite> [<a href="https://doi.org/10.3390/cancers14215362" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9659096/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36358781/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancers&amp;title=Adherens%20junction%20integrity%20is%20a%20critical%20determinant%20of%20sodium%20iodide%20symporter%20residency%20at%20the%20plasma%20membrane%20of%20thyroid%20cells&amp;volume=14&amp;publication_year=2022&amp;pages=5362&amp;pmid=36358781&amp;doi=10.3390/cancers14215362&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib19">
<span class="label">19.</span><cite>Watkins RJ, Read ML, Smith VE, et al. 
Pituitary tumor transforming gene binding factor: a new gene in breast cancer. Cancer Res
2010. 
70
3739–3749. ( 10.1158/0008-5472.can-09-3531)
</cite> [<a href="https://doi.org/10.1158/0008-5472.can-09-3531" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2875163/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20406982/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Res&amp;title=Pituitary%20tumor%20transforming%20gene%20binding%20factor:%20a%20new%20gene%20in%20breast%20cancer&amp;volume=70&amp;publication_year=2010&amp;pages=3739-3749&amp;pmid=20406982&amp;doi=10.1158/0008-5472.can-09-3531&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib20">
<span class="label">20.</span><cite>Fletcher A, Read ML, Thornton CEM, et al. 
Targeting novel sodium iodide symporter interactors ADP-ribosylation factor 4 and valosin-containing protein enhances radioiodine uptake. Cancer Res
2020. 
80
102–115. ( 10.1158/0008-5472.can-19-1957)
</cite> [<a href="https://doi.org/10.1158/0008-5472.can-19-1957" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7470018/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31672844/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Res&amp;title=Targeting%20novel%20sodium%20iodide%20symporter%20interactors%20ADP-ribosylation%20factor%204%20and%20valosin-containing%20protein%20enhances%20radioiodine%20uptake&amp;volume=80&amp;publication_year=2020&amp;pages=102-115&amp;pmid=31672844&amp;doi=10.1158/0008-5472.can-19-1957&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib21">
<span class="label">21.</span><cite>Smith VE, Read ML, Turnell AS, et al. 
PTTG-binding factor (PBF) is a novel regulator of the thyroid hormone transporter MCT8. Endocrinology
2012. 
153
3526–3536. ( 10.1210/en.2011-2030)
</cite> [<a href="https://doi.org/10.1210/en.2011-2030" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22535767/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Endocrinology&amp;title=PTTG-binding%20factor%20(PBF)%20is%20a%20novel%20regulator%20of%20the%20thyroid%20hormone%20transporter%20MCT8&amp;volume=153&amp;publication_year=2012&amp;pages=3526-3536&amp;pmid=22535767&amp;doi=10.1210/en.2011-2030&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib22">
<span class="label">22.</span><cite>Boelaert K, Smith V, Stratford A, et al. 
PTTG and PBF repress the human sodium iodide symporter. Oncogene
2007. 
26
4344–4356. ( 10.1038/sj.onc.1210221)
</cite> [<a href="https://doi.org/10.1038/sj.onc.1210221" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17297475/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncogene&amp;title=PTTG%20and%20PBF%20repress%20the%20human%20sodium%20iodide%20symporter&amp;volume=26&amp;publication_year=2007&amp;pages=4344-4356&amp;pmid=17297475&amp;doi=10.1038/sj.onc.1210221&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib23">
<span class="label">23.</span><cite>Shalem O, Sanjana NE, Hartenian E, et al. 
Genome-scale CRISPR-Cas9 knockout screening in human cells. Science
2014. 
343
84–87. ( 10.1126/science.1247005)
</cite> [<a href="https://doi.org/10.1126/science.1247005" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4089965/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24336571/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Genome-scale%20CRISPR-Cas9%20knockout%20screening%20in%20human%20cells&amp;volume=343&amp;publication_year=2014&amp;pages=84-87&amp;pmid=24336571&amp;doi=10.1126/science.1247005&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib24">
<span class="label">24.</span><cite>Cerami E, Gao J, Dogrusoz U, et al. 
The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov
2012. 
2
401–404. ( 10.1158/2159-8290.cd-12-0095)
</cite> [<a href="https://doi.org/10.1158/2159-8290.cd-12-0095" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3956037/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22588877/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Discov&amp;title=The%20cBio%20cancer%20genomics%20portal:%20an%20open%20platform%20for%20exploring%20multidimensional%20cancer%20genomics%20data&amp;volume=2&amp;publication_year=2012&amp;pages=401-404&amp;pmid=22588877&amp;doi=10.1158/2159-8290.cd-12-0095&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib25">
<span class="label">25.</span><cite>Gao J, Aksoy BA, Dogrusoz U, et al. 
Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal
2013. 
6
pl1. ( 10.1126/scisignal.2004088)
</cite> [<a href="https://doi.org/10.1126/scisignal.2004088" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4160307/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23550210/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Signal&amp;title=Integrative%20analysis%20of%20complex%20cancer%20genomics%20and%20clinical%20profiles%20using%20the%20cBioPortal&amp;volume=6&amp;publication_year=2013&amp;pages=pl1&amp;pmid=23550210&amp;doi=10.1126/scisignal.2004088&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib26">
<span class="label">26.</span><cite>Barrett T, Wilhite SE, Ledoux P, et al. 
NCBI GEO: archive for functional genomics data sets – update. Nucleic Acids Res
2013. 
41
D991–D995. ( 10.1093/nar/gks1193)
</cite> [<a href="https://doi.org/10.1093/nar/gks1193" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3531084/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23193258/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic%20Acids%20Res&amp;title=NCBI%20GEO:%20archive%20for%20functional%20genomics%20data%20sets%20%E2%80%93%20update&amp;volume=41&amp;publication_year=2013&amp;pages=D991-D995&amp;pmid=23193258&amp;doi=10.1093/nar/gks1193&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib27">
<span class="label">27.</span><cite>Tarabichi M, Saiselet M, Trésallet C, et al. 
Revisiting the transcriptional analysis of primary tumours and associated nodal metastases with enhanced biological and statistical controls: application to thyroid cancer. Br J Cancer
2015. 
112
1665–1674. ( 10.1038/bjc.2014.665)
</cite> [<a href="https://doi.org/10.1038/bjc.2014.665" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4430711/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25965298/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Br%20J%20Cancer&amp;title=Revisiting%20the%20transcriptional%20analysis%20of%20primary%20tumours%20and%20associated%20nodal%20metastases%20with%20enhanced%20biological%20and%20statistical%20controls:%20application%20to%20thyroid%20cancer&amp;volume=112&amp;publication_year=2015&amp;pages=1665-1674&amp;pmid=25965298&amp;doi=10.1038/bjc.2014.665&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib28">
<span class="label">28.</span><cite>Landa I, Ibrahimpasic T, Boucai L, et al. 
Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers. J Clin Investig
2016. 
126
1052–1066. ( 10.1172/jci85271)
</cite> [<a href="https://doi.org/10.1172/jci85271" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4767360/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26878173/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Investig&amp;title=Genomic%20and%20transcriptomic%20hallmarks%20of%20poorly%20differentiated%20and%20anaplastic%20thyroid%20cancers&amp;volume=126&amp;publication_year=2016&amp;pages=1052-1066&amp;pmid=26878173&amp;doi=10.1172/jci85271&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib29">
<span class="label">29.</span><cite>Kogai T, Kanamoto Y, Li AI, et al. 
Differential regulation of sodium/iodide symporter gene expression by nuclear receptor ligands in MCF-7 breast cancer cells. Endocrinology
2005. 
146
3059–3069. ( 10.1210/en.2004-1334)
</cite> [<a href="https://doi.org/10.1210/en.2004-1334" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15817668/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Endocrinology&amp;title=Differential%20regulation%20of%20sodium/iodide%20symporter%20gene%20expression%20by%20nuclear%20receptor%20ligands%20in%20MCF-7%20breast%20cancer%20cells&amp;volume=146&amp;publication_year=2005&amp;pages=3059-3069&amp;pmid=15817668&amp;doi=10.1210/en.2004-1334&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib30">
<span class="label">30.</span><cite>Karaman MW, Herrgard S, Treiber DK, et al. 
A quantitative analysis of kinase inhibitor selectivity. Nat Biotechnol
2008. 
26
127–132. ( 10.1038/nbt1358)
</cite> [<a href="https://doi.org/10.1038/nbt1358" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18183025/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat%20Biotechnol&amp;title=A%20quantitative%20analysis%20of%20kinase%20inhibitor%20selectivity&amp;volume=26&amp;publication_year=2008&amp;pages=127-132&amp;pmid=18183025&amp;doi=10.1038/nbt1358&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib31">
<span class="label">31.</span><cite>Wang H, Xu X, Wang J, et al. 
The role of N-myristoyltransferase 1 in tumour development. Ann Med
2023. 
55
1422–1430. ( 10.1080/07853890.2023.2193425)
</cite> [<a href="https://doi.org/10.1080/07853890.2023.2193425" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC10161948/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/37140999/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ann%20Med&amp;title=The%20role%20of%20N-myristoyltransferase%201%20in%20tumour%20development&amp;volume=55&amp;publication_year=2023&amp;pages=1422-1430&amp;pmid=37140999&amp;doi=10.1080/07853890.2023.2193425&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib32">
<span class="label">32.</span><cite>Ducker CE, Upson JJ, French KJ, et al. 
Two N-myristoyltransferase isozymes play unique roles in protein myristoylation, proliferation, and apoptosis. Mol Cancer Res
2005. 
3
463–476. ( 10.1158/1541-7786.mcr-05-0037)
</cite> [<a href="https://doi.org/10.1158/1541-7786.mcr-05-0037" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2908404/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16123142/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Cancer%20Res&amp;title=Two%20N-myristoyltransferase%20isozymes%20play%20unique%20roles%20in%20protein%20myristoylation,%20proliferation,%20and%20apoptosis&amp;volume=3&amp;publication_year=2005&amp;pages=463-476&amp;pmid=16123142&amp;doi=10.1158/1541-7786.mcr-05-0037&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib33">
<span class="label">33.</span><cite>Darrouzet E, Graslin F, Marcellin D, et al. 
A systematic evaluation of sorting motifs in the sodium–iodide symporter (NIS). Biochem J
2016. 
473
919–928. ( 10.1042/bj20151086)
</cite> [<a href="https://doi.org/10.1042/bj20151086" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26831514/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochem%20J&amp;title=A%20systematic%20evaluation%20of%20sorting%20motifs%20in%20the%20sodium%E2%80%93iodide%20symporter%20(NIS)&amp;volume=473&amp;publication_year=2016&amp;pages=919-928&amp;pmid=26831514&amp;doi=10.1042/bj20151086&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib34">
<span class="label">34.</span><cite>Shoji S, Kurosawa T, Inoue H, et al. 
Human cellular src gene product: identification of the myristoylated pp60c-src and blockage of its myristoyl acylation with N-fatty acyl compounds resulted in the suppression of colony formation. Biochem Biophys Res Commun
1990. 
173
894–901. ( 10.1016/s0006-291x(05)80870-8)
</cite> [<a href="https://doi.org/10.1016/s0006-291x(05)80870-8" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/2268350/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochem%20Biophys%20Res%20Commun&amp;title=Human%20cellular%20src%20gene%20product:%20identification%20of%20the%20myristoylated%20pp60c-src%20and%20blockage%20of%20its%20myristoyl%20acylation%20with%20N-fatty%20acyl%20compounds%20resulted%20in%20the%20suppression%20of%20colony%20formation&amp;volume=173&amp;publication_year=1990&amp;pages=894-901&amp;pmid=2268350&amp;doi=10.1016/s0006-291x(05)80870-8&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib35">
<span class="label">35.</span><cite>Patwardhan P &amp; Resh MD. Myristoylation and membrane binding regulate c-Src stability and kinase activity. Mol Cell Biol
2010. 
30
4094–4107. ( 10.1128/mcb.00246-10)
</cite> [<a href="https://doi.org/10.1128/mcb.00246-10" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2937550/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20584982/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Cell%20Biol&amp;title=Myristoylation%20and%20membrane%20binding%20regulate%20c-Src%20stability%20and%20kinase%20activity&amp;volume=30&amp;publication_year=2010&amp;pages=4094-4107&amp;pmid=20584982&amp;doi=10.1128/mcb.00246-10&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib36">
<span class="label">36.</span><cite>Kim S, Alsaidan OA, Goodwin O, et al. 
Blocking myristoylation of src inhibits its kinase activity and suppresses prostate cancer progression. Cancer Res
2017. 
77
6950–6962. ( 10.1158/0008-5472.can-17-0981)
</cite> [<a href="https://doi.org/10.1158/0008-5472.can-17-0981" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5732839/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29038344/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Res&amp;title=Blocking%20myristoylation%20of%20src%20inhibits%20its%20kinase%20activity%20and%20suppresses%20prostate%20cancer%20progression&amp;volume=77&amp;publication_year=2017&amp;pages=6950-6962&amp;pmid=29038344&amp;doi=10.1158/0008-5472.can-17-0981&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib37">
<span class="label">37.</span><cite>Maurer-Stroh S, Eisenhaber B &amp; Eisenhaber F. N-terminal N-myristoylation of proteins: prediction of substrate proteins from amino acid sequence. J Mol Biol
2002. 
317
541–557. ( 10.1006/jmbi.2002.5426)
</cite> [<a href="https://doi.org/10.1006/jmbi.2002.5426" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11955008/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Mol%20Biol&amp;title=N-terminal%20N-myristoylation%20of%20proteins:%20prediction%20of%20substrate%20proteins%20from%20amino%20acid%20sequence&amp;volume=317&amp;publication_year=2002&amp;pages=541-557&amp;pmid=11955008&amp;doi=10.1006/jmbi.2002.5426&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib38">
<span class="label">38.</span><cite>Brandvold KR, Steffey ME, Fox CC, et al. 
Development of a highly selective c-Src kinase inhibitor. ACS Chem Biol
2012. 
7
1393–1398. ( 10.1021/cb300172e)
</cite> [<a href="https://doi.org/10.1021/cb300172e" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3423592/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22594480/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=ACS%20Chem%20Biol&amp;title=Development%20of%20a%20highly%20selective%20c-Src%20kinase%20inhibitor&amp;volume=7&amp;publication_year=2012&amp;pages=1393-1398&amp;pmid=22594480&amp;doi=10.1021/cb300172e&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib39">
<span class="label">39.</span><cite>Schweppe RE, Kerege AA, French JD, et al. 
Inhibition of Src with AZD0530 reveals the Src-focal adhesion kinase complex as a novel therapeutic target in papillary and anaplastic thyroid cancer. J Clin Endocrinol Metab
2009. 
94
2199–2203. ( 10.1210/jc.2008-2511)
</cite> [<a href="https://doi.org/10.1210/jc.2008-2511" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2690419/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/19293266/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Endocrinol%20Metab&amp;title=Inhibition%20of%20Src%20with%20AZD0530%20reveals%20the%20Src-focal%20adhesion%20kinase%20complex%20as%20a%20novel%20therapeutic%20target%20in%20papillary%20and%20anaplastic%20thyroid%20cancer&amp;volume=94&amp;publication_year=2009&amp;pages=2199-2203&amp;pmid=19293266&amp;doi=10.1210/jc.2008-2511&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib40">
<span class="label">40.</span><cite>Cho NL, Lin C-I, Du J, et al. 
Global tyrosine kinome profiling of human thyroid tumors identifies Src as a promising target for invasive cancers. Biochem Biophys Res Commun
2012. 
421
508–513. ( 10.1016/j.bbrc.2012.04.034)
</cite> [<a href="https://doi.org/10.1016/j.bbrc.2012.04.034" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22521882/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochem%20Biophys%20Res%20Commun&amp;title=Global%20tyrosine%20kinome%20profiling%20of%20human%20thyroid%20tumors%20identifies%20Src%20as%20a%20promising%20target%20for%20invasive%20cancers&amp;volume=421&amp;publication_year=2012&amp;pages=508-513&amp;pmid=22521882&amp;doi=10.1016/j.bbrc.2012.04.034&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib41">
<span class="label">41.</span><cite>Kim WG, Guigon CJ, Fozzatti L, et al. 
SKI-606, an Src inhibitor, reduces tumor growth, invasion, and distant metastasis in a mouse model of thyroid cancer. Clin Cancer Res
2012. 
18
1281–1290. ( 10.1158/1078-0432.ccr-11-2892)
</cite> [<a href="https://doi.org/10.1158/1078-0432.ccr-11-2892" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3294177/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22271876/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Cancer%20Res&amp;title=SKI-606,%20an%20Src%20inhibitor,%20reduces%20tumor%20growth,%20invasion,%20and%20distant%20metastasis%20in%20a%20mouse%20model%20of%20thyroid%20cancer&amp;volume=18&amp;publication_year=2012&amp;pages=1281-1290&amp;pmid=22271876&amp;doi=10.1158/1078-0432.ccr-11-2892&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib42">
<span class="label">42.</span><cite>Chan CM, Jing X, Pike LA, et al. 
Targeted inhibition of Src kinase with dasatinib blocks thyroid cancer growth and metastasis. Clin Cancer Res
2012. 
18
3580–3591. ( 10.1158/1078-0432.ccr-11-3359)
</cite> [<a href="https://doi.org/10.1158/1078-0432.ccr-11-3359" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3931551/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22586301/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Clin%20Cancer%20Res&amp;title=Targeted%20inhibition%20of%20Src%20kinase%20with%20dasatinib%20blocks%20thyroid%20cancer%20growth%20and%20metastasis&amp;volume=18&amp;publication_year=2012&amp;pages=3580-3591&amp;pmid=22586301&amp;doi=10.1158/1078-0432.ccr-11-3359&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib43">
<span class="label">43.</span><cite>Chan D, Tyner JW, Chng WJ, et al. 
Effect of dasatinib against thyroid cancer cell lines in vitro and a xenograft model in vivo. Oncol Lett
2012. 
3
807–815. ( 10.3892/ol.2012.579)
</cite> [<a href="https://doi.org/10.3892/ol.2012.579" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3362483/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22740998/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncol%20Lett&amp;title=Effect%20of%20dasatinib%20against%20thyroid%20cancer%20cell%20lines%20in%20vitro%20and%20a%20xenograft%20model%20in%20vivo&amp;volume=3&amp;publication_year=2012&amp;pages=807-815&amp;pmid=22740998&amp;doi=10.3892/ol.2012.579&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib44">
<span class="label">44.</span><cite>Henderson YC, Toro-Serra R, Chen Y, et al. 
Src inhibitors in suppression of papillary thyroid carcinoma growth. Head Neck
2014. 
36
375–384. ( 10.1002/hed.23316)
</cite> [<a href="https://doi.org/10.1002/hed.23316" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4401074/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23729178/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Head%20Neck&amp;title=Src%20inhibitors%20in%20suppression%20of%20papillary%20thyroid%20carcinoma%20growth&amp;volume=36&amp;publication_year=2014&amp;pages=375-384&amp;pmid=23729178&amp;doi=10.1002/hed.23316&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib45">
<span class="label">45.</span><cite>Vanden Borre P, Gunda V, McFadden DG, et al. 
Combined BRAF(V600E)- and SRC-inhibition induces apoptosis, evokes an immune response and reduces tumor growth in an immunocompetent orthotopic mouse model of anaplastic thyroid cancer. Oncotarget
2014. 
5
3996–4010. ( 10.18632/oncotarget.2130)
</cite> [<a href="https://doi.org/10.18632/oncotarget.2130" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4147301/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24994118/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncotarget&amp;title=Combined%20BRAF(V600E)-%20and%20SRC-inhibition%20induces%20apoptosis,%20evokes%20an%20immune%20response%20and%20reduces%20tumor%20growth%20in%20an%20immunocompetent%20orthotopic%20mouse%20model%20of%20anaplastic%20thyroid%20cancer&amp;volume=5&amp;publication_year=2014&amp;pages=3996-4010&amp;pmid=24994118&amp;doi=10.18632/oncotarget.2130&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib46">
<span class="label">46.</span><cite>Beadnell TC, Mishall KM, Zhou Q, et al. 
The mitogen-activated protein kinase pathway facilitates resistance to the src inhibitor dasatinib in thyroid cancer. Mol Cancer Ther
2016. 
15
1952–1963. ( 10.1158/1535-7163.mct-15-0702)
</cite> [<a href="https://doi.org/10.1158/1535-7163.mct-15-0702" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4975658/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27222538/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Mol%20Cancer%20Ther&amp;title=The%20mitogen-activated%20protein%20kinase%20pathway%20facilitates%20resistance%20to%20the%20src%20inhibitor%20dasatinib%20in%20thyroid%20cancer&amp;volume=15&amp;publication_year=2016&amp;pages=1952-1963&amp;pmid=27222538&amp;doi=10.1158/1535-7163.mct-15-0702&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib47">
<span class="label">47.</span><cite>Beadnell TC, Nassar KW, Rose MM, et al. 
Src-mediated regulation of the PI3K pathway in advanced papillary and anaplastic thyroid cancer. Oncogenesis
2018. 
7
23. ( 10.1038/s41389-017-0015-5)
</cite> [<a href="https://doi.org/10.1038/s41389-017-0015-5" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5833015/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29487290/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncogenesis&amp;title=Src-mediated%20regulation%20of%20the%20PI3K%20pathway%20in%20advanced%20papillary%20and%20anaplastic%20thyroid%20cancer&amp;volume=7&amp;publication_year=2018&amp;pages=23&amp;pmid=29487290&amp;doi=10.1038/s41389-017-0015-5&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib48">
<span class="label">48.</span><cite>Mishall KM, Beadnell TC, Kuenzi BM, et al. 
Sustained activation of the AKT/mTOR and MAP kinase pathways mediate resistance to the Src inhibitor, dasatinib, in thyroid cancer. Oncotarget
2017. 
8
103014–103031. ( 10.18632/oncotarget.20488)
</cite> [<a href="https://doi.org/10.18632/oncotarget.20488" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5732707/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29262541/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Oncotarget&amp;title=Sustained%20activation%20of%20the%20AKT/mTOR%20and%20MAP%20kinase%20pathways%20mediate%20resistance%20to%20the%20Src%20inhibitor,%20dasatinib,%20in%20thyroid%20cancer&amp;volume=8&amp;publication_year=2017&amp;pages=103014-103031&amp;pmid=29262541&amp;doi=10.18632/oncotarget.20488&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib49">
<span class="label">49.</span><cite>Rose MM, Espinoza VL, Hoff KJ, et al. 
BCL2L11 induction mediates sensitivity to src and MEK1/2 inhibition in thyroid cancer. Cancers
2023. 
15
378. ( 10.3390/cancers15020378)
</cite> [<a href="https://doi.org/10.3390/cancers15020378" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9856535/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36672327/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancers&amp;title=BCL2L11%20induction%20mediates%20sensitivity%20to%20src%20and%20MEK1/2%20inhibition%20in%20thyroid%20cancer&amp;volume=15&amp;publication_year=2023&amp;pages=378&amp;pmid=36672327&amp;doi=10.3390/cancers15020378&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib50">
<span class="label">50.</span><cite>Mackey JR, Lai J, Chauhan U, et al. 
N-myristoyltransferase proteins in breast cancer: prognostic relevance and validation as a new drug target. Breast Cancer Res Treat
2021. 
186
79–87. ( 10.1007/s10549-020-06037-y)
</cite> [<a href="https://doi.org/10.1007/s10549-020-06037-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7940342/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33398478/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res%20Treat&amp;title=N-myristoyltransferase%20proteins%20in%20breast%20cancer:%20prognostic%20relevance%20and%20validation%20as%20a%20new%20drug%20target&amp;volume=186&amp;publication_year=2021&amp;pages=79-87&amp;pmid=33398478&amp;doi=10.1007/s10549-020-06037-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib51">
<span class="label">51.</span><cite>Xiang C, Gao H, Meng L, et al. 
Functional variable number of tandem repeats variation in the promoter of proto-oncogene PTTG1IP is associated with risk of estrogen receptor-positive breast cancer. Cancer Sci
2012. 
103
1121–1128. ( 10.1111/j.1349-7006.2012.02266.x)
</cite> [<a href="https://doi.org/10.1111/j.1349-7006.2012.02266.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7685090/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22404099/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cancer%20Sci&amp;title=Functional%20variable%20number%20of%20tandem%20repeats%20variation%20in%20the%20promoter%20of%20proto-oncogene%20PTTG1IP%20is%20associated%20with%20risk%20of%20estrogen%20receptor-positive%20breast%20cancer&amp;volume=103&amp;publication_year=2012&amp;pages=1121-1128&amp;pmid=22404099&amp;doi=10.1111/j.1349-7006.2012.02266.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib52">
<span class="label">52.</span><cite>Watkins RJ, Imruetaicharoenchoke W, Read ML, et al. 
Pro-invasive effect of proto-oncogene PBF is modulated by an interaction with cortactin. J Clin Endocrinol Metab
2016. 
101
4551–4563. ( 10.1210/jc.2016-1932)
</cite> [<a href="https://doi.org/10.1210/jc.2016-1932" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5155689/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27603901/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Endocrinol%20Metab&amp;title=Pro-invasive%20effect%20of%20proto-oncogene%20PBF%20is%20modulated%20by%20an%20interaction%20with%20cortactin&amp;volume=101&amp;publication_year=2016&amp;pages=4551-4563&amp;pmid=27603901&amp;doi=10.1210/jc.2016-1932&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib53">
<span class="label">53.</span><cite>Luo J, Zou H, Guo Y, et al. 
SRC kinase-mediated signaling pathways and targeted therapies in breast cancer. Breast Cancer Res
2022. 
24
99. ( 10.1186/s13058-022-01596-y)
</cite> [<a href="https://doi.org/10.1186/s13058-022-01596-y" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9798727/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/36581908/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Breast%20Cancer%20Res&amp;title=SRC%20kinase-mediated%20signaling%20pathways%20and%20targeted%20therapies%20in%20breast%20cancer&amp;volume=24&amp;publication_year=2022&amp;pages=99&amp;pmid=36581908&amp;doi=10.1186/s13058-022-01596-y&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib54">
<span class="label">54.</span><cite>Poole VL &amp; McCabe CJ. Iodide transport and breast cancer. J Endocrinol
2015. 
227
R1–R12. ( 10.1530/joe-15-0234)
</cite> [<a href="https://doi.org/10.1530/joe-15-0234" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26285906/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Endocrinol&amp;title=Iodide%20transport%20and%20breast%20cancer&amp;volume=227&amp;publication_year=2015&amp;pages=R1-R12&amp;pmid=26285906&amp;doi=10.1530/joe-15-0234&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib55">
<span class="label">55.</span><cite>Unterholzner S, Willhauck MJ, Cengic N, et al. 
Dexamethasone stimulation of retinoic acid-induced sodium iodide symporter expression and cytotoxicity of 131-I in breast cancer cells. J Clin Endocrinol Metab
2006. 
91
69–78. ( 10.1210/jc.2005-0779)
</cite> [<a href="https://doi.org/10.1210/jc.2005-0779" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/16234306/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Endocrinol%20Metab&amp;title=Dexamethasone%20stimulation%20of%20retinoic%20acid-induced%20sodium%20iodide%20symporter%20expression%20and%20cytotoxicity%20of%20131-I%20in%20breast%20cancer%20cells&amp;volume=91&amp;publication_year=2006&amp;pages=69-78&amp;pmid=16234306&amp;doi=10.1210/jc.2005-0779&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib56">
<span class="label">56.</span><cite>Kitazono M, Robey R, Zhan Z, et al. 
Low concentrations of the histone deacetylase inhibitor, depsipeptide (FR901228), increase expression of the Na(+)/I(−) symporter and iodine accumulation in poorly differentiated thyroid carcinoma cells. J Clin Endocrinol Metab
2001. 
86
3430–3435. ( 10.1210/jc.86.7.3430)
</cite> [<a href="https://doi.org/10.1210/jc.86.7.3430" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11443220/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Endocrinol%20Metab&amp;title=Low%20concentrations%20of%20the%20histone%20deacetylase%20inhibitor,%20depsipeptide%20(FR901228),%20increase%20expression%20of%20the%20Na(+)/I(%E2%88%92)%20symporter%20and%20iodine%20accumulation%20in%20poorly%20differentiated%20thyroid%20carcinoma%20cells&amp;volume=86&amp;publication_year=2001&amp;pages=3430-3435&amp;pmid=11443220&amp;doi=10.1210/jc.86.7.3430&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib57">
<span class="label">57.</span><cite>Fortunati N, Catalano MG, Arena K, et al. 
Valproic acid induces the expression of the Na+/I− symporter and iodine uptake in poorly differentiated thyroid cancer cells. J Clin Endocrinol Metab
2004. 
89
1006–1009. ( 10.1210/jc.2003-031407)
</cite> [<a href="https://doi.org/10.1210/jc.2003-031407" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14764827/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J%20Clin%20Endocrinol%20Metab&amp;title=Valproic%20acid%20induces%20the%20expression%20of%20the%20Na+/I%E2%88%92%20symporter%20and%20iodine%20uptake%20in%20poorly%20differentiated%20thyroid%20cancer%20cells&amp;volume=89&amp;publication_year=2004&amp;pages=1006-1009&amp;pmid=14764827&amp;doi=10.1210/jc.2003-031407&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib58">
<span class="label">58.</span><cite>Kelkar MG, Senthilkumar K, Jadhav S, et al. 
Enhancement of human sodium iodide symporter gene therapy for breast cancer by HDAC inhibitor mediated transcriptional modulation. Sci Rep
2016. 
6
19341. ( 10.1038/srep19341)
</cite> [<a href="https://doi.org/10.1038/srep19341" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4726020/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26777440/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci%20Rep&amp;title=Enhancement%20of%20human%20sodium%20iodide%20symporter%20gene%20therapy%20for%20breast%20cancer%20by%20HDAC%20inhibitor%20mediated%20transcriptional%20modulation&amp;volume=6&amp;publication_year=2016&amp;pages=19341&amp;pmid=26777440&amp;doi=10.1038/srep19341&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib59">
<span class="label">59.</span><cite>Jumper J, Evans R, Pritzel A, et al. 
Highly accurate protein structure prediction with AlphaFold. Nature
2021. 
596
583–589. ( 10.1038/s41586-021-03819-2)
</cite> [<a href="https://doi.org/10.1038/s41586-021-03819-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8371605/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34265844/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=Highly%20accurate%20protein%20structure%20prediction%20with%20AlphaFold&amp;volume=596&amp;publication_year=2021&amp;pages=583-589&amp;pmid=34265844&amp;doi=10.1038/s41586-021-03819-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="bib60">
<span class="label">60.</span><cite>Varadi M, Anyango S, Deshpande M, et al. 
AlphaFold protein structure database: massively expanding the structural coverage of protein-sequence space with high-accuracy models. Nucleic Acids Res
2022. 
50
D439–D444. ( 10.1093/nar/gkab1061)
</cite> [<a href="https://doi.org/10.1093/nar/gkab1061" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8728224/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/34791371/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nucleic%20Acids%20Res&amp;title=AlphaFold%20protein%20structure%20database:%20massively%20expanding%20the%20structural%20coverage%20of%20protein-sequence%20space%20with%20high-accuracy%20models&amp;volume=50&amp;publication_year=2022&amp;pages=D439-D444&amp;pmid=34791371&amp;doi=10.1093/nar/gkab1061&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/12372067/bin/supplementary_materials.pdf" data-ga-action="click_feat_suppl" class="usa-link">supplementary_materials.pdf</a><sup> (596.9KB, pdf) </sup>
</div></div></section></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from Endocrine-Related Cancer are provided here courtesy of <strong>Bioscientifica Ltd.</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.1530/ERC-24-0312"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/ERC-24-0312.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (2.9 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/12372067/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/12372067/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC12372067%2F%3Freport%3Dclassic%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC12372067/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC12372067/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC12372067/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/40748136/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC12372067/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/40748136/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC12372067/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/12372067/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="QK2IIy0ePUJGWW3v5kGdh8x5DH311WBWrJbnxjCQDNQKz2WFO1Jn56JMkMcGcEXw">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
